Psoriasis: A Study of the Skin Transcriptome and Microbiome by Tanes, Ceylan Ece
Psoriasis: 
A Study of the Skin Transcriptome and Microbiome 
 
 
 
A Thesis 
Submitted to the Faculty 
of 
Drexel University 
by 
Ceylan Ece Tanes 
in partial fulfillment of the 
requirements for the degree 
of 
Doctor of Philosophy 
June 2015 
 
 
 
  
2 
 
© Copyright 2015 
Ceylan Ece Tanes. All Rights Reserved 
This thesis is dedicated to my parents Yalcin and Sabahat Tanes and my sister Zeynep Tanes. 
Their encouragements and unconditional support has kept me going. 
Acknowledgements 
 
I would like to thank my advisor Dr. Aydin Tozeren for his unwavering support and guidance 
throughout my research. His efforts and patience has shaped me into the scientist that I am 
today, for which I am most grateful. I would like to thank my committee members: Dr. Uri 
Hershberg, Dr. Ahmet Sacan, Dr. Suresh Joshi and Dr. Gail Rosen for their support. Their 
involvement in my research has left a lasting impact on the course of my career. I would like to 
thank my colleagues at the Center for Integrated Bioinformatics: Latifa Jackson and Max Shestov 
for their valuable discussions. I would like to thank my friends for always being there for me 
through thick and thin. A special thanks goes to Pablo Huang for his help of countless hours of 
proofreading and his encouragement during the hardest times. Finally, I would like to 
acknowledge my parents Yalcin and Sabahat Tanes and my beloved sister Zeynep Tanes for their 
encouragement and unconditional support. Without their sacrifices, I would not be here. 
  
5 
 
Table of Contents 
Acknowledgements.......................................................................................................................... 4 
Table of Contents ............................................................................................................................. 5 
List of Tables .................................................................................................................................... 7 
List of Figures ................................................................................................................................... 9 
Abstract .......................................................................................................................................... 12 
Introduction ................................................................................................................................... 15 
Motivation ................................................................................................................................. 15 
Background Information ............................................................................................................ 16 
Skin Disorders and Psoriasis ................................................................................................... 16 
DNA Microarrays .................................................................................................................... 17 
Sequencing Technologies ....................................................................................................... 19 
Specific Aim I: Analyzing Psoriasis Transcriptome ......................................................................... 21 
Introduction ............................................................................................................................... 21 
Methods ..................................................................................................................................... 24 
Microarray Datasets ............................................................................................................... 24 
Gene Signatures of the Host .................................................................................................. 25 
Functional Analysis of Gene Signatures ................................................................................. 28 
Signature Comparison between Psoriasis and Wound Healing ............................................. 29 
Signature Comparison between Affymetrix and PIQOR Platforms ....................................... 29 
Results ........................................................................................................................................ 30 
Host Gene Signatures for Skin Diseases ................................................................................. 31 
Biomarker Genes with Drastic Expression Changes in Psoriasis ............................................ 33 
Functional Annotation of Gene Signatures ............................................................................ 35 
Expression Similarities between Psoriasis and Wound Healing ............................................ 37 
Comparison of Gene Signatures between Affymetrix and PIQOR Datasets .......................... 40 
Discussion .................................................................................................................................. 41 
Specific Aim II: Functional Perturbations in Psoriasis Microbiome ............................................... 45 
Introduction ............................................................................................................................... 45 
Methods ..................................................................................................................................... 47 
Obtaining the Microbiome Datasets ...................................................................................... 47 
6 
 
Processing the Microbiome Reads ......................................................................................... 49 
Metagenome Prediction ........................................................................................................ 50 
Commonly Altered Genes between the Host and the Microbiome ...................................... 50 
Results ........................................................................................................................................ 51 
Significantly Altered OTUs ..................................................................................................... 52 
Metagenome Predictions ....................................................................................................... 56 
Significantly Altered Pathways in Psoriasis Microbiome ....................................................... 60 
Orthologous Genes that are Commonly Altered between Host and the Microbiome.......... 60 
Altered KEGG Pathway Expression for Bacterial Invasion of Epithelial Cells in Relation to 
Skin Disease Host Genes ........................................................................................................ 61 
Discussion .................................................................................................................................. 63 
Specific Aim III: Positive Selection Signals in Psoriasis ................................................................... 67 
Introduction ............................................................................................................................... 67 
Methods ..................................................................................................................................... 70 
Identifying Gene Lists ............................................................................................................. 70 
Obtaining Population Level Data ........................................................................................... 71 
Population Differences .......................................................................................................... 72 
Polymorphism Annotations ................................................................................................... 73 
Results ........................................................................................................................................ 73 
Functional Annotation of the HLA Region ............................................................................. 74 
Allele Frequency Distributions of HLA sub-Region ................................................................ 76 
Polymorphisms on the HLA that are Under Positive Selection .............................................. 77 
Discussion .................................................................................................................................. 82 
Conclusions .................................................................................................................................... 85 
Future Work ................................................................................................................................... 89 
Bibliography ................................................................................................................................... 90 
Appendices ..................................................................................................................................... 99 
Appendix A ................................................................................................................................. 99 
Appendix B ............................................................................................................................... 100 
Appendix C ............................................................................................................................... 101 
Curriculum Vitae .......................................................................................................................... 104 
 
7 
 
List of Tables 
Table 1 Summary of skin condition transcriptome datasets obtained from NCBI GEO database 
obtained before January 1st 2014. The numbers of control (C), active uninvolved (U) and active 
lesion (A) skin biopsy samples are presented for each dataset. Only the skin biopsies are 
included in this study. Inclusion criteria such as age, severity of the condition and treatment 
status are also included. The samples are hybridized onto Affymetrix HGU133+2 platform with 
the exception of GSE63741 dataset which is hybridized onto PIQOR Skin 2.0 Microarray. a For the 
Merkel cell carcinoma dataset, U stands for tumor biopsies that tested negative for MCPyV and 
A stands for tumor biopsies that tested positive for MCPyV. b For the wound healing dataset, C 
stands for acute wound; U stands for biopsy at day 3 of healing process; and A stands for biopsy 
at day 7 of healing process………………………………………………………………………………………………………25 
Table 2 Gene signatures obtained from host microarray dataset comparisons. A: Active, U: 
Uninvolved, C: Control; UP: upregulated; DWN: downregulated. The numbers in the table 
indicate the number of genes with significantly altered expression in a comparison. The numbers 
of consensus genes for multiple Affymetrix datasets in the same comparison are shown in bold. 
All the datasets except for GSE63741 have been hybridized onto Affymetrix HGU 133 Plus 2 chip. 
Grey boxes indicate comparisons for which transcriptome data did not exist…………………………..30 
Table 3 Common significant enrichments (Benjamini<0.01) between datasets hybridized onto 
PIQOR and Affymetrix platforms. The values represent the percentage of significant genes 
within the corresponding term. Up: upregulated genes, down: downregulated genes, KEGG: 
Kyoto Encyclopedia of Genes and Genomes, GO: Gene Ontology, BP: Biological Process, MF: 
Molecular Function…………………………………………………………………………………………………………………..40 
Table 4: The number of distinct tissue samples with 16S rRNA sequence datasets presented by 
the Human Microbiome Project (HMP) and American Gut Project (AGP). The 16S rRNA 
sequence reads obtained from skin swabs of active psoriasis lesions, uninvolved contralateral 
skin from psoriatic patients and subjects that don't have any skin conditions (Control) were 
included in the analysis. The remaining samples used for further analysis after quality control 
steps (Usable Samples) as well as the total number of samples in the dataset before the quality 
control step (Total) are reported………………………………………………………………………………………………47 
Table 5 Average Nearest Sequenced Taxon Index (NSTI) for the microbiome datasets based on 
the phylogenetic distance for each organism in the OTU tableto its nearest relative sequenced 
reference genome. All values were within an acceptable range for accurate prediction…………..56 
8 
 
Table 6 KEGG pathways that have significantly different (P<0.01) abundance levels in psoriasis 
microbiome compared to controls calculated with PICRUST. The significance was only observed 
in the microbiome comparisons between uninvolved skin (U) and healthy controls (C). The table 
shows for each listed KEGG pathway, the p value calculated using the Mann-Whitney U test and 
the abundance fold changes……………………………………………………………………………………………………59 
Table 7: Significantly over- and under-represented genes in psoriasis in the host and the 
microbiome for the A/C and A/U comparisons (p<0.01 for host and p<0.05 for microbiome). 
No commonalities were observed for the U/C comparison. The table reflects the fold changes of 
the commonly altered genes in the microbiome and the host, and p values resulting from Mann-
Whitney U test. A: Active involved skin, U: Active uninvolved skin, C: control skin, FC: fold 
change………………………………………………………………………………………………………………………………………60 
Table 8: The HLA region coordinates on chromosome 6 partitioned according to their 
functional class annotations as described in Shiina et al. The coordinates are based on the hg19 
build of the genome. The number of SNPs included in the phased genotypes of the HapMap 
populations as well as the number of phased SNPs that have ancestral annotations according to 
the EPO pipeline. ……………………………………………………………………………………………………………………..70 
Table 9: Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways that are enriched with 
all HLA genes and sub-classes of genes. The terms are significant (Benjamini < 0.01) in at least 1 
gene list. The terms are listed as most commonly enriched to region specific terms. The values 
represent the ratio of genes in the term that overlap with the gene list. The cells that are left 
blank signifies that the corresponding term is not enriched for that gene list. There were no 
terms enriched for extended class II region, hence its corresponding column is not shown………74 
Table 10: Diseases that are associated with the genes under positive selection (iHS Benjamini < 
0.01) in at least one HapMap population. The diseases associated with the gene under positive 
selection are separated as autoimmune, infection, inherited, cancer and other. Genes are sorted 
according to their genomic positions. The associated diseases are obtained through the 
MalaCards database.…………………………………………………………………………………………………………………80 
  
9 
 
List of Figures 
Figure 1 Flowchart of microarray analysis steps. The raw microarray samples are downloaded 
and normalized. Significant genes are obtained through statistical analysis and processed though 
functional annotation datasets..……………………………………………………………………………………………….29 
Figure 2 Soerensen Coefficient for Pairs of Comparisons. Soerensen similarity coefficient 
calculated for the a) 200 upregulated and b) 200 downregulated genes with the highest fold 
change for each pair of gene signatures. Coefficient ranges in value from 0 (no overlap, shown in 
black) to 1 (perfect overlap, shown in white). The conditions under study are as follows: 
psoriasis (PS), atopic dermatitis (AD), allergic contact dermatitis (ACD), Merkel cell carcinoma 
(MCC) and wound healing (WND). A: Active involved, U: active uninvolved, C: healthy control 
samples……………………………………………………………………………………………………………………………………31 
Figure 3 Top genes in psoriasis signature and the corresponding log 2 transformed fold 
changes in all comparisons. The upregulated genes are indicated with shades of red and the 
downregulated genes are indicated with shades of blue. The genes with epidermal 
differentiation complex (EDC), antimicrobial and lipid processing functions are marked in black. 
PS: psoriasis, AD: atopic dermatitis, ACD: allergic contact dermatitis, SA: sarcoidosis, MCC: 
Merkel cell carcinoma, WND: wound healing. A: Active involved, U: active uninvolved, C: healthy 
control samples…………………………………………………………………………………………………………………………33 
Figure 4 Significantly upregulated (pink) and downregulated (blue) KEGG pathways 
(Benjamini<0.05) of the psoriasis microarray datasets of the host. The width of each slice is 
proportional to the ratio of significant genes in the pathway. The pathways are categorized 
according to KEGG-BRITE hierarchy (inner circle). Pathways significantly altered in other skin 
conditions are marked outside of the corresponding pathway slices. PS:psoriasis, AD:atopic 
dermatitis, ACD:allergic contact dermatitis, MCC:Merkel cell carcinoma, WND:wound healing..35 
Figure 5 Number of genes that are common between the consensus psoriasis gene signatures 
(A/C/ and A/U) and wound healing gene signatures (A/C and U/C) for a) upregulated and b) 
downregulated genes. The genes in the color coded regions have been annotated with GP-BP 
Level 5 terms. The top 5 enrichments are reported in their corresponding colored boxes. The 
colored regions that don’t have associated annotations provided did not have any significant 
enrichments (Benjamini < 0.01). ………………………………………………………………………………………………37 
10 
 
Figure 6 Psoriasis (A/C, A/U) and wound (A/C, U/C) upregulated genes (Benjamini<0.01 and 
fold change>1.5) overlapped with the KEGG pathway cytokine-cytokine receptor interaction 
pathway. The cytokines that are commonly upregulated as well as the ones that are exclusive to 
one conditions can be seen. PS_AC: psoriasis A/C consensus gene signature, PS_AU: psoriasis 
A/U consensus gene signature, WND_AC: wound healing reconstructive stage gene signature, 
WND_UC: wound healing inflammatory stage gene signature………………………………………………….38 
Figure 7 Flowchart of microbiome analysis steps. The 16S rRNA sequence reads were 
downloaded, passed through quality control steps and assigned to OTUs. The metagenome was 
predicted through PICRUST package. ……………………………………………………………………………………….51 
Figure 8: Average bacterial phylum level abundance of microbiome in patients with psoriasis 
and healthy controls from different body sites. Actinobacteria, Firmicutes and Proteobacteria 
dominate the phyla in each body site. ……………………………………………………………………………………..52 
Figure 9 Bacterial class level abundance of microbiome in patients with psoriasis and healthy 
controls for only the elbow samples based on the Human Microbiome Project data. Bacterial 
classes that have more than 10% abundance in more than 1 sample were labeled in the bar 
graph. The rest of the classes are categorized as “other”. The classes that are shown were 
annotated with their phylum memberships..…………………………………………………………………………….52 
Figure 10: The OTUs significantly altered (Benjamini<0.05) in psoriasis lesions compared to 
healthy controls in the human skin microbiome for the pooled samples from all body sites. All 
the OTUs were lower in abundance in psoriasis lesions. The OTUs that are statistically significant 
(q<0.05) for the non-singleton body sites (elbow, knee, back, leg, forearm) are labeled with red 
stars.…………………………………………………………………………………………………………………………………………54 
Figure 11: The OTUs significantly altered (p<0.01) in psoriasis lesions compared to healthy 
controls in the human skin microbiome. The nodes are labeled with Green Genes OTU 
numbers, the phyla, and the most specific level of categorization that is available with the OTUs 
such as species (s), genus (g) and family (f). The abundance perturbations are noted with an up 
pointing arrow for higher abundance in psoriasis and down pointing arrow for lower abundance 
OTUs. The colors represent the body site where the OTU is significant (red:elbow, blue:knee)..55 
Figure 12 the orthologous genes that are consistently altered in the microbiome comparisons. 
The values represent the log2 transformed fold changes of the metagenome predicted through 
PICRUST software package. The high abundance genes are indicated with shades of red and the 
low abundance genes are indicated with shades of blue………………………………………………………….58 
11 
 
Figure 13 Bacterial invasion of epithelial cells KEGG pathway annotated with the up and 
downregulated gene signatures for psoriasis. The genes targeted by bacteria (blue) and viruses 
(red) obtained from PHISTO database are indicated with lines under the gene boxes/ The 
virulence factors obtained from VfDB database are indicated with red stars. The over and 
underrepresented microbial genes obtained from metagenome analysis of the psoriasis 
microbiome are marked with red arrows. PS: psoriasis, up: upregulated genes, down: 
downregulated genes, target_bac: bacterial target, target_vir: viral target………………………………61 
Figure 14 Flowchart of the analysis shows the steps taken to obtain the SNPs that are under 
positive selection in the HLA region for each population as well as identifying the SNPs that have 
significantly different population histories…………………………………………..……………………………………73 
Figure 15: Heatmaps of pairwise SNP allele frequency distribution comparisons using the 
Kolmogorov-Smirnov (KS) test for each cluster. The values represent the -log10 of the Benjamini 
FDR corrected KS-test p values. The comparisons that are not significant (Benjamini>0.05) are in 
black.………………………………………………………………………………………………………………………………………..76 
Figure 16: Superposition of –log10 of the Benjamini corrected iHS p-values of all HapMap 
populations along the HLA region. The horizontal red line represents cutoff for significance 
(Benjamini<0.01). Class I region shows evidence of positive selection with European (CEU, TSI) 
specificity, non-specific ethnic background positive selection in Class III, African (LWK, YRI) 
specificity in the Class II region and no positive selection in extended Class II region………………..78 
Figure 17: The SNPs with significantly different evolutionary backgrounds between at least 
two populations belonging to different geographical regions (Benjamini<0.01). The 
standardized ratio of integrated site-specific EHH from pairwise populations (Rsb) on the HLA 
region were calculated. Each box represents a gene annotated with the SNPs that have 
significantly different evolutionary backgrounds. The genes are labeled with the HLA sub-regions 
they belong to.………………………………………………………………………………………………………………………….79 
  
12 
 
Abstract 
Psoriasis: A Study of the Skin Transcriptome and Microbiome 
Ceylan Ece Tanes 
Aydin Tozeren, PhD 
 
Psoriasis is a complex autoimmune skin disorder characterized by dry, scaly plaques and painful 
flares. Even though genetic contribution and environmental factors are suspected, the exact 
trigger of psoriasis is not well understood. The chronic condition of the disease and the lack of 
effective and definitive treatments are burdens on the patients. Recent emergence of 
transcriptome and genomic datasets for the host, as well as the taxonomic datasets for the 
microbiome has enabled the use of bioinformatics approaches to investigate altered gene 
circuits in psoriasis. 
As a first step, open source microarray datasets of psoriasis were analyzed in context of other 
skin conditions. The analysis showed that upregulated genes in the psoriasis transcriptome 
included those involved in epidermal differentiation complex and antimicrobial processes, while 
the top downregulated genes were involved in lipid metabolism. The Kyoto Encyclopedia of 
Genes and Genomes (KEGG) pathways that were enriched with significantly altered genes point 
to the upregulation of both innate and adaptive immune responses. The psoriasis gene 
signature was distinctive from other inflammatory skin conditions and it resembled the wound 
healing process in terms of keratinization and immune response signals. 
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On the microbiome side, over-abundance of opportunistic bacteria on the psoriasis microbiome 
was observed compared to controls. Virulence genes were consistently in high abundance 
across different body sites. Bacterial invasion of epithelial cells gene pathway was crowded with 
both significantly altered genes on the host side and high-abundance orthologs on the 
microbiome side. The findings suggested bacterial involvement in the initiation or maintenance 
of psoriasis flares.  
Genetic components also play a role in susceptibility to psoriasis. Human Leukocyte Antigen 
(HLA) is one of the regions that has previously been associated with psoriasis through Genome 
Wide Association studies. The Single Nucleotide Polymorphisms (SNPs) typed in the HapMap 
dataset (11 ethnic populations) within the HLA region have been analyzed using extended 
haplotype homozygosity based tests to identify positive selection on polymorphisms that have 
not yet reached fixation. Results showed regional specificity of positive selection signals on the 
sub-classes of HLA. The positive selection signals in Class I sub-region showed European ancestry 
specificity with intronic SNPs on a psoriasis related gene PSORS1C1 as well as on TCF19, MUC22, 
TRIM10, and TRIM15. The region specific selection signals were also seen in the Class III region 
for the East Asian populations and in the Class II region for African ancestry populations. Similar 
to single population tests, the cross population tests showed that the significant SNPs were 
concentrated in the Class II region for African ancestry populations, whereas for European 
ancestry populations, they were concentrated in the Class I region. The results show how 
positive selection of a SNP can encourage genetic hitchhiking of the susceptibility SNPs for a 
disease along with a SNP that is under positive selection. 
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This research thesis bridges large scale transcriptome datasets of the host and operational 
taxonomy unit abundance datasets of the microbiome, opening up new avenues for drug 
repositioning studies by pointing out specific host-microbiome genes as drug targets. 
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Introduction 
Motivation  
This research is dedicated to investigating psoriasis as a complex disease through gene 
expression, microbiome, and genetic susceptibility analysis. Although the literature contains 
psoriasis research using these approaches individually, the bridge between the three 
perspectives is still lacking. There is hence a need to integrate between multiple microarray 
datasets to investigate psoriasis in the broad spectrum of skin conditions and bridging them with 
microbiome functional perturbations. The combination of the results from the two analyses can 
provide a comprehensive perspective of the cross-talk between host and the microbiome. 
Furthermore the genomic aspect of psoriasis can be identified by positive selection regions in 
the highly disease and psoriasis associated HLA region. 
Psoriasis has an extensive number of open source datasets available for meta-analysis, however 
the datasets that have been curated for this study for both microarray and microbiome will 
continue to expand over time. Therefore, the methodology and approach described in this 
thesis will have the ability to incorporate new datasets and study other autoimmune conditions 
as they become available in the future. 
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Background Information 
Skin Disorders and Psoriasis 
Autoimmune disorders currently affect 5% of the Western population and are on the rise, with 
more than seventy subtypes [1]. Current drugs on the market prescribed to manage 
autoimmune diseases are of the anti-inflammatory type used primarily to subdue the symptoms 
and does not provide complete treatment. These disorders are hypothesized to arise when the 
immune system reacts to self, in addition to non-self antigens through the relaxation of negative 
selection for T-cells and B-cells. This results in the accumulation of clones that recognize major 
histocompatibility complex (MHC) molecules. The resulting inflammation damages and can 
eventually destroy the affected tissues [2]. In our lab, inflammatory bowel disease has been 
extensively studied using transcriptome data to provide a deeper understanding of autoimmune 
disease mechanisms [3]. 
The skin is an organ commonly affected by autoimmune conditions, either as the primary target 
such as psoriasis, atopic dermatitis, and allergic contact dermatitis, or through secondary 
manifestations such as dermatomyositis or sarcoidosis. Due to their chronic nature, they have 
negative effects on the quality of life of the patient in terms of economic burden, pain 
management, social discrimination, and mental status [4, 5].  
Among the skin related autoimmune conditions, psoriasis has a 1.4 – 3% prevalence across 
Europe and the United States [6]. It is a chronic inflammatory condition in which the 
keratinocytes proliferate and differentiate resulting in skin thickening [7]. Even though the exact 
trigger for psoriasis is not fully understood, genetic disposition [8] and environmental conditions 
17 
 
[9] are known risk factors. Psoriatic patients (approximately 70%) have a peak onset between 
the ages of 16-22 [10]. The symptoms for psoriasis can be alleviated with anti-inflammatory 
drugs, topical treatments, and dietary regimen [11, 12]. Psoriasis treatment adherence is 
challenging due to concerns regarding long-term safety and drug efficacy [6]. The chronic nature 
of the disease calls for life-long maintenance and high healthcare cost [13]. Approximately 20% 
of patients with psoriasis are also diagnosed with psoriatic arthritis within a decade of initial 
diagnosis [6]. Comorbidities including cardiovascular conditions [14, 15], psoriatic arthritis [16], 
type II diabetes [17], and inflammatory bowel disease [18] cause additional long term physical 
and economical strain for the patient [19].  
In order to study psoriasis, high throughput technologies are required to understand the 
complex and multi-level nature of the disease. Microarray technologies that quantify the 
amount of mRNA in the samples are used to observe gene expression changes in the 
hyperproliferating keratinocytes in the context of other skin conditions. SNPchip microarrays are 
used to detect the polymorphisms in different populations. The genotypes can be utilized to 
better understand the susceptibility differences observed across populations. Finally, high 
throughput sequencing technologies are useful in confirming suspected microbiome 
contributions to the psoriasis phenotype. Understanding the pathology of psoriasis through 
transcriptomic and genomic datasets will aid in creating better, more effective treatments to 
increase patient quality of life and decrease associated life-long economic burdens. 
DNA Microarrays 
DNA microarrays are high throughput technologies to detect the relative concentration of 
nucleic acid sequences that are extracted from a sample of interest. In DNA microarrays, short 
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nucleic acid sequences, called probes, are bound to a platform. They rely on DNA base pairing 
between the probes and the tested sequences. Relative concentrations are calculated from 
fluorescent labeling techniques. This technology has been used for manufacturing high 
throughput gene expression, transcription binding, and genotyping platforms [20]. 
Gene expression levels in a sample are detected using mRNA microarrays. One of the major 
companies that produce microarrays is Affymetrix. Their core technology identifies and 
synthesizes species specific 25 nucleotide length oligonucleotide sequences onto the microarray 
platform surface. The RNA segments extracted from the samples of interest are processed and 
labeled with fluorescent markers. The microarray platform is washed with the extracted 
sequences to promote hybridization and fluorescence intensities are subsequently quantified by 
confocal microscopy. The intensities correlate directly to corresponding gene expression levels 
[20].  
The single nucleotide polymorphism genotyping platforms manufactured by Affymetrix rely on a 
similar method where pairs of oligonucleotides are used to represent the alleles on the genome. 
Each pair of oligonucleotides differ at only one position in the middle of the sequence that 
represent the two alleles of a SNP. The DNA is extracted from the samples, labeled with 
fluorescent markers, and hybridized onto the platform synthesized with the oligonucleotides. 
The image that is captured from the fluorescent labeling can then determine if the sample of 
interest is homozygous in one of the two alleles or heterozygous. 
Both the expression and genotyping arrays have been utilized in this research to understand the 
psoriasis phenotype. The expression arrays have been utilized to detect mRNA perturbations in 
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psoriasis skin. Genotype data from the HapMap project [21] have been used to discover the 
genetic contribution to the susceptibility differences observed in psoriasis. 
Sequencing Technologies 
Since the draft of the human genome in 2001, sequencing technologies have improved to 
provide more sequence reads per run at a significantly lower cost. This has paved the way for 
large scale efforts such as the 1000 Genomes Project [22] and Human Microbiome Project [23]. 
Through these efforts, genomes of bacteria and model organisms have been decoded. Besides 
genomic characterization of organisms in their healthy state, sequencing technologies have also 
made it possible to depict disease states. Various projects have been funded such as decoding 
the genome of cancer patients [24] and sequencing the microbiome communities of patients 
with autoimmune disorders [25]. Whereas microarrays can only test for what they are designed 
to detect, sequencing allows for the detection of less annotated regions of the genome and can 
therefore be used to detect novel biomarkers [26].  
Current sequencing technologies follow the same essential steps with slight variations 
depending on the manufacturer. First, adapters are ligated at the ends of the DNA fragments to 
be sequenced. The fragments are then amplified on a solid surface such as a glass slide or a 
microbead by a polymerase mediated process. The nucleotides that are added are detected 
automatically using fluorescence. The detection procedure varies for different technologies and 
ranges from measuring bioluminescent signals to four-color imaging of single molecular events 
[26, 27].  
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One application of sequencing technologies is for detecting the bacterial composition of an 
environment by sequencing 16S ribosomal RNA. 16S rRNA is a component of the ribosome that 
is present in every organism. It is made up of conserved regions that can be selectively targeted 
during sequencing, but it is also composed of variable regions ideal for differentiating between 
organisms. Depending on the capabilities of the technology used, sequencing one or more of the 
variable regions makes it possible to record the bacterial composition of an environment when 
mapped against a 16S library. To date 16S sequencing has been utilized to categorize bacteria 
into their appropriate taxonomy using sequence similarity instead of phenotypic traits. It has 
also been used to identify novel bacterial species and diagnose culture negative infections [28]. 
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Specific Aim I: Analyzing Psoriasis Transcriptome 
The primary aim of this chapter is to uncover statistically significant gene expression alterations 
in psoriasis lesions compared to uninvolved skin and healthy controls. My hypothesis is that the 
meta-analysis of multiple psoriasis microarray datasets will aid in generating a robust gene 
expression signature for psoriasis. Psoriasis will likely share gene expression markers with other 
inflammatory skin conditions, while having a set of distinct genes that can be used as 
biomarkers. Higher level functional annotations of skin conditions will provide similarities 
between the conditions pointing to common inflammatory responses in the skin conditions of 
interest. 
 
Introduction 
Psoriasis is a complex inflammatory condition characterized by keratinocyte hyperproliferation, 
epidermal differentiation, and immune cell infiltration [7]. It has also been defined as aberrant 
wound healing due to uncontrolled thickening of the epidermis [29]. To understand the disease 
as a whole, a systemic approach using microarray expression analysis of psoriasis lesions in 
context with other skin conditions is necessary. 
Various microarray studies have been conducted to investigate the lesional and non-lesional 
psoriasis expression profiles compared to healthy controls. Inflammatory signatures altered in 
psoriasis lesions have been identified such as TNF-alpha, IFN-gamma signaling [30], and Th17 
immune response [31]. Among the genes that have psoriasis associated SNPs positioned on 
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them, the highest expression was seen in neutrophils, signifying a genetic component for the 
inflammatory response [32]. Meta-analysis of the psoriasis microarray datasets revealed that 
the gene signature is most consistent within the same microarray platform [33, 34]. The studies 
selected in this chapter were hybridized onto the widely used and comprehensive Affymetrix 
HGU133+2 microarray platform. The results were later compared to a study hybridized onto 
PIQOR platform for validation. 
Since psoriasis only effects humans and primates [35], animal models have not been insightful 
on the full spectrum of the disease. Comparing microarray gene signatures of human psoriasis 
biopsies and mouse disease models showed that even though there are expression similarities 
between the progression of the disease in terms of keratinization and epidermal differentiation, 
each mouse model had slight variations on psoriasis inflammatory signatures [36]. In general, 
there have been conflicting studies on the correlation of mouse and human inflammatory 
signatures [37, 38]. In order to evaluate the most genuine representation of psoriasis flares, this 
chapter will only focus on the expression profiles of human skin biopsies. 
Psoriasis and atopic dermatitis are the two most common autoimmune skin conditions. Small 
inflammatory expression differences could be observed between psoriasis and atopic dermatitis 
[39]. Meta-analysis of psoriasis, atopic dermatitis, nickel allergy, and acne transcriptome 
signatures showed a unifying gene signature that was T cell mediated but with different sets of 
chemokines upregulated for each condition [40, 41]. For example, while psoriasis was Th17 
mediated, atopic dermatitis was Th2 mediated. However they both had neutrophil 
chemoattractant expressions in common [39]. The results were further confirmed with a 
microarray study including five inflammatory skin conditions where IL-17 and TNF-alpha signals 
were exclusively predominant in psoriasis lesions [42]. Among the comparative studies in 
23 
 
literature, a microarray meta-analysis of multiple skin conditions is needed to reach a unifying 
conclusion about the commonalities and differences between psoriasis and other skin 
conditions.  
Wound healing is significantly accelerated in patients with psoriasis compared to healthy 
controls [43]. The two conditions also show similarities with respect to increased keratinocyte 
proliferation and differentiation. During wound healing, chemoattractants are released to 
regulate neutrophils and IL-8 is essential in re-epithelialization signaling [44]. Due to their 
similarities, when gene targets and biomarkers are selected for psoriasis, it is crucial to analyze 
wound healing transcriptome alongside of inflammatory skin conditions to differentiate 
between which altered genes are beneficial for the organism to heal wounds and the genes that 
result in an aberrant wound healing response such as psoriasis. 
Merkel cell carcinoma is an aggressive cutaneous cancer with mortality rate greater than 30%. It 
has been observed that 75% of Merkel Cell carcinomas contain Merkel cell polyomavirus. Clonal 
integration of the virus to the host cells implicates viral origins of the cancer [45]. Psoriasis and 
atopic dermatitis are autoimmune conditions that have suspected bacterial involvements [46]. 
Therefore the Merkel Cell carcinoma dataset was included in the analysis even though the 
pathology of the disease varies from autoimmune definition. 
Since the development of microarray technologies, sequencing has become cheaper and 
available, making way for high-throughput complementary DNA sequencing (RNA-seq) as an 
alternative to microarray studies. RNA-seq study by Bingshan et al. has expanded the psoriasis 
transcriptome, especially in the immune system process [47]. Even though RNA-seq data would 
provide a more sensitive analysis of the expression profiles of skin conditions, not enough 
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studies have been performed to carry out a meta-analysis. Therefore, in order to put psoriasis in 
context of other skin conditions, microarray datasets have been utilized as they provide a rich 
source of data. 
Overall, this chapter focuses on the meta-analysis of psoriasis microarray datases in context of 
other inflammatory conditions (atopic dermatitis and allergic contact dermatitis), an aggressive 
skin cancer with suspected viral origins and natural wound healing process making it the most 
comprehensive analysis of psoriasis transcriptome in literature.  
 
Methods 
Microarray Datasets 
NCBI Gene Expression Omnibus (GEO) [48] was queried with the search term “skin” and 
“GPL570” for skin biopsy microarray datasets hybridized onto Affymetrix Human Genome U133 
Plus 2.0 GeneChip Array. This platform is commonly used and is a comprehensive gene chip 
representing almost 19,000 genes. The datasets (before January 1st 2014) obtained were further 
narrowed down by selecting skin condition studies which include at least five skin biopsy 
samples, each from at least two of the flare-up (A), uninvolved skin (U), and healthy control (C) 
categories. The search criteria yielded 14 datasets as summarized in Table 1. From these 
datasets, only the untreated samples have been included in the study. The datasets were 
processed using robust multiarray averaging (RMA) background adjustment and quantile 
normalization [49]. The resulting probe expression data were mapped onto Entrez Gene IDs 
using the custom chip description file (cdf) [50] using median polishing [49]. 
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The microarray dataset GSE63741 hybridized onto PIQOR Skin 2.0 platform was also included in 
the analysis due to its extensive coverage of inflammatory skin conditions [42]. The dataset 
represented 30 samples each from healthy controls, as well as psoriasis, atopic dermatitis, and 
allergic contact dermatitis patients. In this chapter the dataset has been used to compare the 
robustness of expression profiles across platforms as well as validate the gene signatures 
obtained for each skin condition. The normalized expression values for the dataset were 
downloaded from NCBI GEO [48] for further processing. 
Gene Signatures of the Host 
For the Affymetrix datasets, gene signatures were obtained for the following comparisons: 
active involved versus active uninvolved samples (A/U), active involved versus healthy controls 
(A/C), and active uninvolved versus healthy controls (U/C). Lists of significantly upregulated and 
downregulated genes were obtained for each comparison using (a) Significance Analysis of 
Microarray (SAM) [51] and (b) Rank Product (RP) method [52]. Significant gene lists determined 
from the analyses had a q-value cutoff of 0.01 and fold change cutoff above 1.5. The 
intersection of the SAM and RP tests were considered as the gene signature for a given 
comparison in a single dataset. A consensus gene list was obtained with rth ordered p-value 
meta-analysis method [53] over multiple datasets by finding the genes that are significant in 
more than half of the datasets. 
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GSE # Condition Publication C U A Age 
Treatment Criteria for 
Eligibility 
Severity 
Biopsy 
diameter 
14905 Psoriasis Yao et al., 2008 21 28 33 - - moderate to severe - 
13355 
Plaque 
Psoriasis 
Swidell et al., 2009 64 58 58 
21-69 (PS) 
18-45 (C) 
No systemic treatments 2 
weeks prior, no topical 
treatments 1 week prior to 
study 
≥1% of body effected 
 
6 mm 
34248 
Plaque 
Psoriasis 
Bigler et al., 2013 0 14 14 19-55 No treatment 
moderate to severe 
≥10% of body effected 
PASI ≥10 
5 mm 
41663 
Plaque 
Psoriasis 
Bigler et al., 2013 0 15 15 19-55 No treatment 
moderate to severe 
≥10% of body effected 
PASI ≥10 
- 
41662 
Plaque 
Psoriasis 
Bigler et al., 2013 0 24 24 19-55 No treatment 
moderate to severe 
≥10% of body effected 
PASI ≥10 
6 mm 
30999 
Plaque 
Psoriasis 
Suarez-Farinaz et al, 
2012. 
0 85 85 - 
No systemic treatments 4 
weeks prior, no topical 
treatments 2 weeks, no 
biological agent 3 months prior 
to study 
moderate to severe 
≥10% of body effected 
4 mm 
63741 
Plaque 
Psoriasis 
D’Erme et al., 2015 30 0 30 - No treatment - - 
 
32924 
Atopic 
dermatitis 
Suarez-Farinaz et 
al., 2011 
8 12 13 16-81 
No treatment 4 weeks prior to 
study 
SCORAD 28-97.5 
11-63% of body effected 
- 
36842 
Atopic 
dermatitis 
Gittler et al., 2012 15 8 16 20-67 
No treatment 4 weeks prior to 
study 
SCORAD 40-63 - 
27887 
Atopic 
dermatitis 
Tintle et al., 2011 0 8 9 24-51 
Patients allowed to use 
emollients 
SCORAD 28-97.5 4-6 mm 
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16161 
Atopic 
dermatitis 
Guttman-Yassky et 
al, 2009. 
9 0 9 
28-54 (AD) 
24-69 (C) 
No treatment 4 weeks prior to 
study 
SCORAD 20-70 - 
63741 
Atopic 
dermatitis 
D’Erme et al., 2015 30 0 30 - No treatment - - 
 
6281 
Allergic 
contact 
dermatitis 
Pedersen et al., 
2007 
16 9 9 
33-49 
(ACD) 
31-55 (C) 
No immunosuppressants during 
study 
At least 2+ reaction to 5% 
nickel sulfate 
4 mm 
63741 
Allergic 
contact 
dermatitis 
D’Erme et al., 2015 30 0 30 - No treatment - - 
 
39612a 
Merkel cell 
carcinoma 
Harms et al., 2013 64 16 19 59-88 - Stage I-III - 
 
28914b 
Wound 
healing 
Nuutila et al., 2012 6 6 5 20-75 NA NA 3 mm 
Table 2 Summary of skin condition transcriptome datasets obtained from NCBI GEO database obtained before January 1st 2014. The numbers 
of control (C), active uninvolved (U) and active lesion (A) skin biopsy samples are presented for each dataset. Only the skin biopsies are included 
in this study. Inclusion criteria such as age, severity of the condition and treatment status are also included. The samples are hybridized onto 
Affymetrix HGU133+2 platform with the exception of GSE63741 dataset which is hybridized onto PIQOR Skin 2.0 Microarray. a For the Merkel cell 
carcinoma dataset, U stands for tumor biopsies that tested negative for MCPyV and A stands for tumor biopsies that tested positive for MCPyV. b 
For the wound healing dataset, C stands for acute wound; U stands for biopsy at day 3 of healing process; and A stands for biopsy at day 7 of 
healing process. 
 
 
28 
 
The average rank of a significant gene for a given comparison was calculated based on the SAM 
fold changes in order to find the set of consistently upregulated and downregulated genes 
across multiple datasets of a condition. The top 25 genes from the significantly upregulated and 
downregulated psoriasis ranked sets were used as biomarker genes and their functional 
memberships were further characterized. The fold changes were clustered using hierarchical 
clustering to determine if the genes can be used to distinguish psoriasis from other skin 
conditions. 
The expression values of the disease samples hybridized onto PIQOR platform were compared 
against the control samples using SAM and RP methods in order to get significantly altered 
genes with a Benjamini cutoff of 0.01 and fold change cutoff of 1.5. The overlap of the two 
methods composed the disease profiles for the PIQOR platform, consistent with the steps taken 
to analyze Affymetrix datasets. 
Functional Analysis of Gene Signatures 
The pair wise gene signature intersections were quantified with Soerensen coefficient 
(SC=2∥A∩B∥/(∥A∥+∥B∥), where A and B are two separate sets) [54] to test the similarity 
between different conditions as well as the consistency between the datasets of the same 
condition. The Bioconductor GOstats package [55] was used for statistical enrichment of Gene 
Ontology Biological Process (GO-BP) [56] and the Kyoto Encyclopedia of Genes and Genomes 
(KEGG) pathways [57] in consensus signatures. The p-values were corrected with the Benjamini-
Hocheberg method [58] to account for false discovery. The representative condition 
enrichments were obtained by assigning the smallest identified p-value from the three 
comparisons (A/C, A/U, U/C). KEGG pathways were mapped into their BRITE categories [59], 
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which provided a hierarchical classification of pathways. The same enrichment steps were taken 
to perform functional annotation of the PIQOR significant gene lists. Significantly enriched KEGG 
pathways were annotated with virulence factors using the Virulence Factors Database (VfDB) 
[60, 61], while the viral and bacterial proteins that are known to bind with the human proteins 
were identified using Pathogen-Host Interaction Search Tool (PHISTO) [62]. 
Signature Comparison between Psoriasis and Wound Healing 
Due to the observed expression similarities between psoriasis lesions and wound healing 
process, the gene signatures of both conditions were further examined. The consensus A/C and 
A/U gene signature of psoriasis were overlapped with reconstructive (A/C) and inflammatory 
(U/C) gene signatures of wound healing process. The comparison of gene signatures were 
grouped as follows: reconstructive stage of wound healing genes overlapped with any psoriasis 
genes, inflammatory stage of wound healing genes overlapped with any psoriasis genes, 
common inflammatory and reconstructive stages of wound healing genes overlapped with any 
psoriasis genes, wound healing specific genes and psoriasis specific genes. The top five GO-BP 
Level 5 processes enriched were found. The gene signatures have also been projected onto the 
cytokine-cytokine receptor interaction KEGG pathway in order to visualize the differences in 
immune function in both processes. 
Signature Comparison between Affymetrix and PIQOR Platforms 
The gene signatures obtained for psoriasis, atopic dermatitis and allergic contact dermatitis 
were compared between Affymetrix and PIQOR platforms using hypergeometric test to evaluate 
the robustness of gene signatures across microarray platforms. For the test, only the genes that 
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are represented on both platforms have been considered. The KEGG, GO-BP and GO-MF 
enrichments (Benjamini < 0.01) of the gene signatures obtained from both platforms were also 
compared. 
 
Results 
Fourteen publicly available microarray datasets were analyzed for the host consisting of 977 
samples (Table 1). Each skin condition included samples from healthy controls (C), active 
uninvolved (U), and active involved (A) stages. Transcriptome datasets for five different skin 
conditions were utilized: psoriasis (PS) [19, 30, 34, 36], atopic dermatitis (AD) [63-66], allergic 
contact dermatitis (ACD) [67], Merkel cell carcinoma (MCC) [68], and wound healing (WND) [69].  
 
 
Figure 1 Flowchart of microarray analysis steps. The raw microarray samples are downloaded 
and normalized. Significant genes are obtained through statistical analysis and processed though 
functional annotation datasets. 
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Host Gene Signatures for Skin Diseases 
The microarray datasets shown in Table 1 were normalized and analyzed as described in 
Methods and summarized in Figure 1. The numbers of significant genes obtained for each 
microarray dataset, as well as the consensus signatures over all datasets for a given disease are 
shown in Table 2. Psoriasis signatures were highly similar across the six datasets yielding 801 
consensus upregulated and 578 downregulated genes in active/control (A/C) comparison among 
the 18,959 genes on the microarray chip. MCC had the largest significant gene list, a common 
feature of signatures associated with cancer [70]. 
    A/C A/U U/C 
Condition Dataset UP DWN UP DWN UP DWN 
PS 
GSE14905 1376 1317 1101 936 182 244 
GSE13355 1008 880 929 666 11 7 
GSE34248     956 1081     
GSE41663     1074 1266     
GSE41662     1359 1584     
GSE30999     1265 1187     
consensus 801 578 907 836 4 1 
GSE63741 197 169     
AD 
GSE32924 705 514 0 0 217 272 
GSE36842 2280 2175 0 0 1217 1513 
GSE27887     0 0     
GSE16161 759 720 
  
    
consensus 644 551 0 0 66 165 
GSE63741 104 72     
ACD 
GSE6281 790 1103  311 106   219 379  
GSE63741 168 139     
MCC GSE39612 2592 2873 538 566 2594 3108 
WND GSE28914 505 394 4 1 659 405 
 
Table 2 Gene signatures obtained from host microarray dataset comparisons. A: Active, U: 
Uninvolved, C: Control; UP: upregulated; DWN: downregulated. The numbers in the table 
indicate the number of genes with significantly altered expression in a comparison. The numbers 
of consensus genes for multiple Affymetrix datasets in the same comparison are shown in bold. 
All the datasets except for GSE63741 have been hybridized onto Affymetrix HGU 133 Plus 2 chip. 
Grey boxes indicate comparisons for which transcriptome data did not exist.  
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Similarity of gene signatures across datasets was considered by calculating the Soerensen 
coefficient (SC) [54] for the top 200 most significant genes from sets of pairwise gene signatures. 
Heatmap diagrams in Figure 2 point to high levels of similarity between the six psoriasis datasets 
in A/U and A/C comparisons. Averaging over the six datasets, SC was equal to 0.65 for 
upregulated and 0.45 for downregulated genes. Approximately half of the top 200 genes for 
psoriasis and for process of wound healing were the same. In contrast, atopic dermatitis gene 
signatures for A/C and U/C comparisons were more heterogeneous. Moreover there was little 
overlap between gene signatures of allergic contact dermatitis and Merkel cell carcinoma. 
 
 
 
Figure 2 Soerensen Coefficient for Pairs of Comparisons. Soerensen similarity coefficient 
calculated for the a) 200 upregulated and b) 200 downregulated genes with the highest fold 
change for each pair of gene signatures. Coefficient ranges in value from 0 (no overlap, shown in 
black) to 1 (perfect overlap, shown in white). The conditions under study are as follows: 
psoriasis (PS), atopic dermatitis (AD), allergic contact dermatitis (ACD), Merkel cell carcinoma 
(MCC) and wound healing (WND). A: Active involved, U: active uninvolved, C: healthy control 
samples 
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Biomarker Genes with Drastic Expression Changes in Psoriasis 
The top 25 most upregulated genes in the consensus list for psoriasis were altered up to a fold-
change of 300. As such, they comprised a candidate biomarker set for psoriasis. The fold change 
patterns of these genes were investigated across the six skin disorders being studied. Figure 3 
shows that biomarker candidate genes for psoriasis undergo much less dramatic expression 
changes in other skin disorders. Hierarchical clustering of the identified gene fold changes 
showed close clustering of A/U and A/C psoriasis comparisons confirming the distinctive role of 
those genes as psoriasis biomarkers. Wound healing U/C and A/C comparisons which represent 
the inflammatory and reconstructive stages of wound healing also cluster closely with psoriasis 
datasets.  
The upregulated biomarker genes in Figure 3 were previously associated with psoriasis through 
expression studies [33, 71-75]. However the downregulated genes identified (TSPAN8, 
SCGB1D2, C5orf46, IL37, RBP4, PPARGC1A, CA6, NR3C2, ZSCAN18, and GSTA3) have not been 
linked to psoriasis since the emphasis of previous studies were predominantly on upregulated 
genes as possible biomarkers. The top upregulated genes include those part of the epidermal 
differentiation complex (EDC) (S100A7A, S100A9, S100A12, SPRR2A, SPRR2C); antimicrobial 
peptides (LCN2, TMPRSS11D, PI3, S100A7A, S100A9, OASL), structural proteins (KRT6C, KRT16, 
GDA), metalloproteinases (ADAMDEC1, MMP12), and the serpine peptidase inhibitors 
(SERPINB3 and SERPINB4). Top downregulated genes including THRSP, H19, LPL, PPARGC1A, 
RBP4, and HSD11B1 play important roles in lipid processes. PPARGC1A, known to interact with 
PPARgamma has previously been associated with psoriasis [76]. PPARs are a family of genes that 
communicate between lipid metabolic disorders, Th17 response, and innate immunity [77]. 
HSD11B1 codes a microsomal enzyme that catalyzes the conversion of the stress hormone 
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cortisol to the inactive metabolite cortisone. The downregulated biomarkers showed similarities 
to Merkel cell carcinoma and wound healing.  
 
Figure 3 Top genes in psoriasis signature and the corresponding log 2 transformed fold 
changes in all comparisons. The upregulated genes are indicated with shades of red and the 
downregulated genes are indicated with shades of blue. The genes with epidermal 
differentiation complex (EDC), antimicrobial and lipid processing functions are marked in black. 
PS: psoriasis, AD: atopic dermatitis, ACD: allergic contact dermatitis, SA: sarcoidosis, MCC: 
Merkel cell carcinoma, WND: wound healing. A: Active involved, U: active uninvolved, C: healthy 
control samples 
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Functional Annotation of Gene Signatures 
The consensus gene lists obtained for each skin condition were annotated using statistical 
enrichment of KEGG pathways [57] and GO-BP [56]. Figure 4 shows KEGG pathways enriched 
with significantly upregulated (pink) and significantly downregulated (blue) genes in psoriasis, 
with a Benjamini cutoff of 0.05. The outer edge of the figure shows the pathways enriched for 
the other five skin conditions. The three most upregulated KEGG pathways for psoriasis are 
cytokine-cytokine receptor interaction, cell cycle, and NOD-like receptor signaling pathways. 
These three pathways illustrate the involvement of the innate and adaptive immune system 
mechanisms in psoriasis, as well as increased cell overturn in the progression of the flares. 
Functional enrichment of other skin conditions revealed adaptive and innate inflammatory 
pathways that are also commonly upregulated with psoriasis. The downregulated pathways in 
psoriasis include organismal pathways such as the PPAR signaling pathway, which is a hormone-
signaling pathway activated by fatty acids. The significantly downregulated pathways are 
typically psoriasis specific and show less commonality with other conditions.  
Overall, the pathway enrichment results confirm previous findings [78, 79] and reveal new 
psoriasis enrichment results, including cytosolic DNA sensing and RIG-I like receptor signaling. In 
addition, as shown in Figure 4, a number of disease pathways were statistically enriched with 
psoriasis significant genes. These disease pathways include rheumatoid arthritis, malaria, and 
cardiovascular disease. The KEGG disease pathways annotated with psoriasis gene signatures 
can be seen in Appendix A and Appendix B. The latter of which were previously linked to 
psoriasis in the literature [19, 33]. Furthermore, malaria treatment has a risk of triggering 
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psoriasis [80]. Genes marked in these disease pathways shed light on the molecular mechanisms 
linking psoriasis to its comorbidities.  
 
 
Figure 4 Significantly upregulated (pink) and downregulated (blue) KEGG pathways 
(Benjamini<0.05) of the psoriasis microarray datasets of the host. The width of each slice is 
proportional to the ratio of significant genes in the pathway. The pathways are categorized 
according to KEGG-BRITE hierarchy (inner circle). Pathways significantly altered in other skin 
conditions are marked outside of the corresponding pathway slices. PS: psoriasis, AD: atopic 
dermatitis, ACD: allergic contact dermatitis, MCC: Merkel cell carcinoma, WND: wound healing 
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Functional enrichment analysis of the disease signatures for GO-BP [56] terms show 
upregulation of type I interferon signaling in all skin conditions except Merkel cell carcinoma. 
The GO annotations for downregulated genes show clear functional segregation, in which terms 
related to muscle development and cell adhesion are downregulated in psoriasis. Keratinization 
shows heterogeneity with respect to skin disease subtype, where it is upregulated in psoriasis 
and wound healing and downregulated in atopic dermatitis and Merkel cell carcinoma. GO-BP 
term for defense response to virus is enriched in significant gene lists for psoriasis, atopic 
dermatitis, allergic contact dermatitis, and sarcoidosis, pointing to potential pathogenic 
involvement in autoimmune conditions.  
Expression Similarities between Psoriasis and Wound Healing 
As observed in Figure 3, the fold change profiles of the reconstructive (A/C) and inflammatory 
(U/C) stages of the wound healing process clustered with psoriasis biomarker profiles. This was 
further investigated by comparing significantly expressed genes involved in wound healing and 
psoriasis gene signatures. The overlapping number of genes between the profiles and their top 
five significant GO-BP Level 5 enriched terms can be seen in Figure 5. There are 448 genes 
associated with wound healing that overlap between either A/C or A/U psoriasis gene 
signatures. The GO-BP annotations of these genes show functional differences depending on 
which wound gene signature they overlap with. The psoriasis gene signature that overlaps 
exclusively with A/C wound signature is mainly related to keratinization and epidermis 
development. This is consistent with epidermal regeneration that is observed in wound healing 
and high keratinization of psoriasis lesions. The genes that overlap with the U/C wound 
signature exclusively are related to T cell regulatory functions such as CD80, CD83, IL2RG and 
IL4R. The genes that are exclusive to wound healing have further regulation of inflammatory 
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response such as IL10, IL6, TNFRSF1B and TLR8. Finally the genes that are common between 
psoriasis gene signatures and both stages of wound healing have genes related to mitosis. This 
correlates to the high cell overturn that is observed in both conditions. The genes that are 
common for downregulated genes did not show functional coherence except for psoriasis 
exclusive genes, which were related to muscle development. 
 
 
Figure 5 Number of genes that are common between the consensus psoriasis gene signatures 
(A/C/ and A/U) and wound healing gene signatures (A/C and U/C) for a) upregulated and b) 
downregulated genes. The genes in the color coded regions have been annotated with GP-BP 
Level 5 terms. The top five enrichments are reported in their corresponding colored boxes. The 
colored regions that don’t have associated annotations provided did not have any significant 
enrichments (Benjamini < 0.01). 
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The psoriasis and wound healing gene signatures have been projected onto the cytokine-
cytokine receptor interaction pathway to visualize the expression of cytokines in both conditions 
as illustrated in Figure 6. Cytokines CXCL1, CXCL2, IL7R, and IL1B were expressed commonly 
between psoriasis and wound healing, whereas CXCL5, CXCL6, CCR1, IL6, IL10, IL24, and IL1A 
were expressed exclusively in wound healing, and CXCL9, CXCL11, IL12, IL19, IL20, IL26, and 
TNFSF10 were expressed exclusively in psoriasis lesions. 
 
Figure 6 Psoriasis (A/C, A/U) and wound (A/C, U/C) upregulated genes (Benjamini < 0.01 and 
fold change > 1.5) overlapped with the KEGG pathway cytokine-cytokine receptor interaction 
pathway. The cytokines that are commonly upregulated as well as the ones that are exclusive to 
one conditions can be seen. PS_AC: psoriasis A/C consensus gene signature, PS_AU: psoriasis 
A/U consensus gene signature, WND_AC: wound healing reconstructive stage gene signature, 
WND_UC: wound healing inflammatory stage gene signature. 
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Comparison of Gene Signatures between Affymetrix and PIQOR Datasets 
Even though Affymetrix Human Genome U133 Plus 2 is a comprehensive microarray chip that is 
widely used, other microarray technologies such as PIQOR have been used for skin studies. In 
order to assess the robustness of gene signatures across platforms, a study hybridized onto 
PIQOR array was analyzed. The microarray chip used for the GEO dataset GSE63741 [42] is 
PIQOR Skin 2.0 Microarray which represents 1542 skin specific genes. When the consensus gene 
signatures obtained from Affymetrix datasets were compared against PIQOR gene signatures for 
each condition, the hypergeometric tests were all significant with p-values smaller than 3e-4. 
This signifies that, among the genes that were common between the two platforms, the mRNA 
perturbations observed were equivalent.  
Between the two microarray platforms, there were discrepancies with the functional 
annotations done through KEGG and GO databases, most likely due to the reduced number of 
genes that the PIQOR chip covers. The details of the terms enriched can be seen in Table 3. For 
example if the upregulated gene signatures of psoriasis are considered, even though there were 
18 pathways that were enriched with Affymetrix obtained genes and four pathways that were 
enriched with PIQOR obtained genes, the only consensus between the two platforms were 
NOD-like receptor signaling pathway. There was a higher number of overlap for the GO-BP 
functional enrichments. For the psoriasis upregulated genes, the commonly enriched terms 
included keratinization, type I interferon-mediated signaling pathway, negative regulation of 
viral genome replication, and regulation of response to stress. 
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Database Direction Term PIQOR Affymetrix 
KEGG up NOD-like receptor signaling pathway 0.12 0.27 
GO-MF up interleukin-1 receptor binding 0.25 0.38 
GO-MF up serine-type endopeptidase inhibitor activity 0.08 0.15 
GO-MF up peptidase inhibitor activity 0.06 0.13 
GO-MF up endopeptidase regulator activity 0.06 0.13 
GO-MF down glutathione transferase activity 0.30 0.35 
GO-MF down heparin binding 0.06 0.13 
GO-BP up keratinization 0.36 0.50 
GO-BP up type I interferon-mediated signaling pathway 0.32 0.49 
GO-BP up peptide cross-linking 0.29 0.25 
GO-BP up response to type I interferon 0.17 0.30 
GO-BP up negative regulation of viral genome replication 0.16 0.37 
GO-BP up interferon-gamma-mediated signaling pathway 0.14 0.27 
GO-BP up negative regulation of endopeptidase activity 0.09 0.22 
GO-BP up regulation of response to stress 0.04 0.11 
GO-BP down extracellular matrix organization 0.07 0.13 
 
Table 3 Common significant enrichments (Benjamini < 0.01) between datasets hybridized onto 
PIQOR and Affymetrix platforms. The values represent the percentage of significant genes 
within the corresponding term. Up: upregulated genes, down: downregulated genes, KEGG: 
Kyoto Encyclopedia of Genes and Genomes, GO: Gene Ontology, BP: Biological Process, MF: 
Molecular Function 
 
Discussion 
Psoriasis is a complex autoimmune condition with a high economic and psychological burden on 
the patients. Microarray studies conducted on various skin conditions allow for a systems 
approach to mRNA perturbations. In this chapter, multiple psoriasis microarray studies have 
been analyzed in context of other skin conditions to compare and contrast their expression 
profiles.  
We find that psoriasis has robust and consistent upregulation of gene circuit patterns across a 
multitude of microarray datasets. Psoriasis signature was specific enough that the top 
upregulated genes could differentiate psoriasis accurately from other skin diseases based on 
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unsupervised clustering of fold changes. Psoriasis lesions, when compared to healthy controls, 
shared inflammatory and reconstructive processes with the process of wound healing, as 
evidenced by the shared upregulated biomarkers. 
Host pathways significantly enriched with upregulated genes in psoriasis corresponded to the 
immune system, cellular processes, environmental information processing, genetic information 
processing, and metabolic categories. Upregulated psoriasis genes were also significantly 
enriched in disease pathways of psoriasis comorbidities such as rheumatoid arthritis. For 
example, proteins related to the Th17 response [81] in rheumatoid arthritis pathway such as 
CXCL1, IL8, CCL20, CCL2, and CD80/86 are also upregulated in psoriasis. Shared inflammatory 
features in psoriasis and arthritis [82] suggest the presence of a cascade eventually causing joint 
degeneration [83]. Genes contributing to joint cartilage destruction such as MMP1/3 and CTSL 
are upregulated across psoriasis datasets. The genes that are commonly upregulated should be 
further investigated to better understand the link between psoriasis and its comorbidities. 
Host pathways enriched with downregulated psoriasis genes include a number of disease 
pathways such as dilated or hypertrophic cardiomyopathy as presented in Appendix A. In these 
pathways, genes coding the transmembrane protein sarcoglycan and contractility proteins actin, 
troponin, tropomyosin, and desmin are downregulated in psoriasis. The consequences of the 
downregulation of sets of transmembrane proteins in psoriasis are yet to be fully explored. 
This chapter shows genes involved in antimicrobial function are consistently upregulated in 
psoriasis. These findings are consistent with the skin's role as the major physical barrier between 
self and non-self, with these antimicrobial genes providing the first line of defense against 
bacterial and viral pathogens [84]. Antimicrobial genes provide defense against a multitude of 
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pathogens: gram positive and gram negative bacteria as well as viral agents [46, 85]. The 
upregulation in the antimicrobial peptides on the skin correlates with recent studies on 
perturbed skin microbial flora in psoriasis and other skin diseases [86-88]. Biopsy studies show 
bacterial presence in the lower levels of the skin [87] and in the blood of patients with psoriasis 
[89], suggesting pathogenic invasion. The upregulated Th17 response is crucial in host response 
to viral infection [90].  
Psoriasis has been defined as aberrant wound healing due to abnormal thickening of the 
epidermis [29]. As with psoriasis, wound healing has an inflammatory and a reconstructive 
component. The results of this chapter show that there are differences in the immune responses 
mounted between psoriasis and wound healing processes. Understanding the differences 
between the two can be beneficial in developing psoriasis drugs with more mild side effects. For 
example an immunosuppressive agent, Sirolimus, has been investigated to treat psoriasis with 
positive results [91]. However one of the side effects is impaired wound healing and wound 
dehiscence [92]. Treatments with wound healing specific genes and agonists for psoriasis 
specific genes can mitigate the side effects of therapies and provide a healthier inflammatory 
response. IL-10 which is exclusive to wound healing has been associated with decreased 
inflammatory response in wound healing and reduced scar formation [93]. IL10 treatment for 
psoriasis has already been underway to test its effectiveness [94]. Even though IL6 expression 
was exclusive to wound healing in our analysis and can possibly be a drug target for psoriasis 
treatment, there is evidence of IL6 expression in both psoriasis and wound healing in literature 
[95, 96]. It is claimed that the high expression of the gene prevents T cells from responding to 
regulation in psoriasis. As for the psoriasis specific genes, there are already prescriptions for IL-
12 agonist [97]. IL-20 has been explored as psoriasis treatment with no efficacy [Clinical Trials: 
44 
 
NCT01261767]. On the other hand IL-19, CXCL9 and CXCL11 have not yet been explored as drug 
targets.  
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Specific Aim II: Functional Perturbations in Psoriasis Microbiome 
The primary aim of this chapter is to identify the microbiome perturbations of the psoriatic skin 
compared to healthy control to identify the bacterial Operational Taxonomic Units (OTUs) and 
the functional perturbations that are significantly altered in psoriatic lesions. The microbiome of 
each individual is likely to contribute to the psoriasis phenotype. The second hypothesis is that 
the functional changes in the microbiome will be mirrored by the processes occurring in the 
host skin. Despite the varying OTUs across the sampled body sites, core orthologs in the 
psoriasis microbiome is expected to become altered. 
 
Introduction 
Psoriasis has been evaluated through genetic, epigenetic, transcriptome, and microbiome 
assays. However, the functional perturbations of the host and the microbiome has not yet been 
bridged. In this chapter the transcriptome gene signature of the host along with the functional 
perturbations on the microbiome side are studied to further the understanding of the host-
microbiome interactions on psoriatic skin. 
Bacterial culture based studies showed correlations of certain bacterial infections and increased 
severity of psoriasis. A study done by Gudjonsson et al showed that patients with psoriasis were 
more likely to contract Streptococcus infections, which in turn exacerbated plaque psoriasis 
[98]. A similar study demonstrated that even though the prevalence of H. pylori was not higher 
in psoriasis than in the control group, those infected by it had a greater severity of plaque 
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psoriasis [99]. The strain of the bacteria colonization is also significant in the severity of psoriasis 
plaques. Patients with psoriasis that were colonized with enterotoxin positive Staphylococcus 
aureus bacteria had higher severity scores than toxin negative psoriasis patients or patients 
without S. aureus colonization [100]. These observations were further supported clinically, with 
patients showing better recovery when they were prescribed antibiotics as part of their 
treatment regimen [99]. Even though culture based studies capture the perturbations of well-
known pathogens, they can miss the effects of non-culturable bacteria on psoriasis severity or 
pathogenesis. It is also unclear whether skin microbiome perturbations have an effect on the 
abundance of virulence factors known to cause human disease. 
In stark contrast to culture-based studies, recent advancements in high throughput sequencing 
technologies and enhanced RNA extraction methods have enabled large-scale 16S based 
microbiome studies, evaluating alterations in bacterial abundance on psoriatic skin. The current 
16S microbiome studies have concluded that the diversity and composition of bacterial flora is 
altered on psoriasis flares. Phylum level abundance differences can be observed for Firmicutes, 
Actinobacteria, and Proteobacteria [86, 87, 101]. The studies that focus on analyzing 
Operational Taxonomic Units (OTUs) alone do not allude the undergoing functional differences 
of the microbiome. The microbiome differences between individuals [102] also make it difficult 
to evaluate the contributions of low-abundance bacteria.  
Even though whole genome shotgun metagenomics sequencing of the skin microbiome would 
provide a more complete picture of bacterial abundance and diversity, such a study has not yet 
been reported and the skin microbiome studies have been limited to 16S data. This is due to the 
low number of reference genomes for the skin isolates, difficulty in culturing certain skin specific 
bacteria, and the challenges in obtaining sterile host DNA samples [102]. Therefore this chapter 
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focuses on extrapolating 16S OTU level abundance data using the database of decoded bacterial 
genomes to predict the ortholog composition of the samples. This provides a preview of the 
functional perturbations that are observed on the skin and is applicable to study cross talk 
interactions in other skin diseases with suspected microbiome involvement such as atopic 
dermatitis [101]. A follow up study can be conducted once robust methods have been 
developed for skin whole genome shotgun metagenomics sequencing.  
 
Methods 
Obtaining the Microbiome Datasets 
NCBI Short Read Archive (SRA) [103] was queried with the search terms “skin metagenome 
psoriasis” or “skin microbiome psoriasis”. This resulted in two datasets (before June 2014) 
belonging to the Human Microbiome Project [23, 25] and the American Gut Project [104]. The 
number of samples present in each of these datasets is recorded in Table 4.  
Analogous to the samples obtained for the microarrays in Chapter 1, the Human Microbiome 
Project samples represented swabs from active psoriasis lesions (A), uninvolved contralateral 
skin (U), and from subjects without any skin conditions (C). The dataset represented samples 
from 14 body sites. Among the body sites of origin only the elbow, knee, back, forearm, and leg 
had five or more samples each from at least two categories (A, U or C). Skin microbiome 
composition is highly dependent on the body site [102]. Therefore the analyses were conducted 
separately for each body site containing enough samples. The V1-3 regions of the 16S rRNA 
bacterial sequences were extracted and sequenced with Roche 454 GS FLX System. Eligible 
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patients had moderate to severe psoriasis. The control samples were age matched to patients 
with psoriasis (18-75 years). Eligibility criteria excluded subjects with systemic antibiotics, 
corticosteroids, cytokine treatments, large consumption of probiotics one month prior to the 
study, and topical antibiotic or steroid applications one week prior. 
American Gut Project samples consisted of swabs from subjects with no skin condition (C) and 
with psoriasis (U). The samples were collected from the hands and forehead. However only the 
forehead samples had more than five samples in both C and U categories. 16S rRNA reads from 
bacterial rDNA V4 regions sequenced on Illumina MiSeq platforms were downloaded from the 
NCBI Short Read Archive (SRA) database [103]. 
 
Body 
Site 
Number of Samples (Usable Samples / Total) Dataset 16S Region 
Control  Uninvolved 
Psoriasis 
Active 
Psoriasis 
Total 
Elbow 35/37 21/22 23/23 79/82 HMP V1-3 
Knee 28/28 11/11 11/11 50/50 HMP V1-3 
Back 0 12/13 12/13 24/26 HMP V1-3 
Leg 0 8/8 8/8 16/16 HMP V1-3 
Forearm 1/1 7/7 7/7 15/15 HMP V1-3 
Other 12/15 15/15 15/15 42/45 HMP V1-3 
Forehead 46/69 5/5 0 51/74 AGP V4 
Total 122/150 79/81 76/77 277/308  
 
Table 4: The number of distinct tissue samples with 16S rRNA sequence datasets presented by 
the Human Microbiome Project (HMP) and American Gut Project (AGP). The 16S rRNA 
sequence reads obtained from skin swabs of active psoriasis lesions, uninvolved contralateral 
skin from psoriatic patients, and subjects without any skin conditions (Control) were included in 
the analysis. The remaining samples used for further analysis after quality control steps (Usable 
Samples) as well as the total number of samples in the dataset before the quality control step 
(Total) are reported. 
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Processing the Microbiome Reads 
From the samples that were included in this study, low quality sequences were filtered with the 
Quantitative Insights into Microbial Ecology (QIIME) [105] tool. Since the two datasets were 
sequenced with different technologies, optimal quality control procedures were followed as 
described in QIIME pipelines for each dataset. The sequences from HMP samples, sequenced 
with the Roche 454 platform, were selected for further processing if they were above an 
average Phred score of 25, and if the sequence lengths were between 200 and 1000 amino 
acids. For the AGP dataset, sequenced with the Illumina MiSeq platform, the quality threshold 
was set at a Phred score of 20. The sequences were truncated after every three consecutive low 
quality reads. After the truncation step, if 75% of the consecutive reads passed the quality 
threshold, the sequence was kept for further processing. 
The sequences retained after the quality control step were assigned Operational Taxonomic 
Units (OTUs) with 97% identity using the 16S reference database: Green Genes version 13_5 
[106]. The samples in the AGP dataset were then rarefied with an OTU threshold of 15,000. 
Samples in the HMP were rarefied to an OTU threshold of 1500 to have uniform sequencing 
depth. These threshold values were chosen to retain sufficient samples while preserving 
diversity of the skin flora.  
The abundance of the OTUs in active psoriasis samples were compared to healthy control 
samples with Mann-Whitney U test for all the body sites combined. The significance test was 
then repeated for each body site separately to see the contribution of individual body sites to 
the OTU significance. 
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Metagenome Prediction 
The OTU tables for each body site were fed into the Phylogenetic Investigation of Communities 
by Reconstruction of Unobserved States (PICRUST) [107] pipeline for further analysis. The 
abundances were normalized with this pipeline to account for 16S copy number variations for 
each OTU. The metagenomes were then inferred by multiplying the normalized OTU 
abundances with the precalculated gene content predictions. The process resulted in 
estimations of the ortholog gene contents of the microbiome and subsequent categorization by 
KEGG pathways. The accuracy of the metagenome predictions were calculated with Nearest 
Sequenced Taxon Index (NSTI) scores. The ortholog genes that were significantly altered in A/C, 
A/U, and U/C comparisons were identified using Mann-Whitney U test with a p-value threshold 
of 0.01. Mann-Whitney U test [108] was also used for A/C, A/U, and U/C comparisons for each 
body site to identify the KEGG Pathways with significantly different abundance levels. 
The fold change of the metagenome predictions of the mentioned comparisons were calculated 
to evaluate the set of orthologs that are commonly altered across body sites. The resulting fold 
changes of each comparison were ranked. The top ranking 25 high and 25 low abundance 
orthologs were visualized.  
Commonly Altered Genes between the Host and the Microbiome 
Expression profiles of the host have been obtained from the meta-analysis of psoriasis studies 
hybridized onto the Affymetrix platform, as described in the previous chapter. Gene signatures 
from active involved versus active uninvolved (A/U), active involved versus healthy controls 
(A/C), and active uninvolved versus healthy controls (U/C) comparisons have been used in this 
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chapter. The gene expression of psoriatic skin does not correlate with body site or age onset 
[109], therefore the psoriasis samples from microarray have been annotated as either 
uninvolved (U) or active (A) regardless of body site. 
To find the genes that were commonly altered between the host and the microbiome, the 
corresponding Entrez IDs of the KEGG orthologs were extracted from the KEGG database. The 
genes that have been significantly altered (p < 0.01) both in the host and the microbiome were 
recorded. 
 
Results 
Psoriasis is an autoimmune condition with suspected microbial involvement. In an effort to 
explore the perturbations of bacterial composition, the 16S sequences extracted from the 
psoriasis lesions, uninvolved and healthy skin, have been sequenced in previous studies as part 
of the Human Microbiome Project [25] and the American Gut Project [104]. This chapter utilizes 
the mentioned studies and the annotated bacterial genomes to extrapolate from OTU 
abundances to microbial gene contents and functional perturbations in psoriasis lesions. 
Alterations of the microbiome’s orthologous gene content in psoriasis lesions were analyzed 
using QIIME [105] and PICRUST [107] packages. The overview of the methods is illustrated on 
the flowchart in Figure 7. 
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Figure 7 Flowchart of microbiome analysis steps. The 16S rRNA sequence reads were 
downloaded, passed through quality control steps and assigned to OTUs. The metagenome was 
predicted through PICRUST package. The host gene expression signatures obtained for the first 
specific aim have been used to find the commonly altered genes in both the host and the 
microbiome. 
 
Significantly Altered OTUs 
After the quality control steps, OTUs were assigned through the QIIME software package. The 
average relative frequencies of the phyla that are found in the microbiome are shown in Figure 
8. The majority of the skin microbiome phyla in both control subjects and microbiome samples 
consisted of Proteobacteria, Firmicutes, and Actinobacteria. Even though the abundance levels 
of the phyla showed minor perturbations, the differences were not statistically significant 
between psoriasis and healthy control samples for individual body sites. Figure 9 shows the class 
level breakdown of the samples collected from the elbow. There are ten main classes of bacteria 
that are commonly present in all samples with varying abundance levels. The abundance 
perturbations of these major phyla or classes in any of the body sites were not significant 
according to the Mann-Whitney U test with a p-value of 0.01. 
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Figure 8: Average bacterial phylum level abundance of microbiome in patients with active 
psoriasis, contralateral uninvolved skin and healthy controls from different body sites. The 
phyla Actinobacteria, Firmicutes and Proteobacteria dominate each body site. 
 
 
Figure 9 Bacterial class level abundance of microbiome in patients with psoriasis and healthy 
controls for only the elbow samples based on the Human Microbiome Project data. Bacterial 
classes that have more than 10% abundance in more than one sample were labeled in the bar 
graph. The rest of the classes are categorized as “other”. The bacterial classes that are shown 
were annotated with their respective phylum memberships. 
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Significant differences in bacterial OTU abundance can be observed between psoriasis lesions 
and healthy skin as quantified by the non-parametric Mann-Whitney U test and corrected for 
false discovery rate with the Benjamini false discovery rate correction method. When the 
samples from each studied body site were pooled and tested for significance, all but two OTUs 
belonged to the phylum Proteobacteria. Within the Proteobacteria phylum, multiple OTUs 
belonging to the Methylobacteriaceae family had significantly lower abundance in psoriasis 
microbiome. The combined phylogenetic tree of the significantly altered OTUs can be seen in 
Figure 10. Most of the body sites in the HMP dataset had less than five samples for each 
category. Therefore the same significance test was repeated excluding the body sites that didn’t 
have enough samples. When the test was repeated with only the pooled samples from elbow, 
knee, back, leg, and forearm body sites, the OTUs belonging to the family Methylobacteriaceae 
continued to be in low abundance in psoriasis active flares compared to healthy controls. 
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Figure 10: The OTUs significantly altered (Benjamini < 0.05) in psoriasis lesions compared to 
healthy controls in the human skin microbiome for the pooled samples from all body sites. All the 
OTUs were lower in abundance in psoriasis lesions. The OTUs that are statistically significant 
(Benjamini < 0.05) for the non-singleton body sites (elbow, knee, back, leg, forearm) are labeled with 
red stars.  
 
Due to the bacterial composition differences across body sites [102], the significance of the 
OTUs were tested separately for each body site. Most differences involved higher abundance of 
OTUs on the knee and lower abundance in the elbow for psoriasis lesions compared to healthy 
controls. The OTUs, such as the ones belonging to the genus Corynebacterium and 
Staphylococcus were known opportunistic bacteria with respect to infection. Although there 
was no OTU commonly altered in more than one skin site, their toxonomy converged at a higher 
phylum level. They belonged to the phyla Firmicutes, Proteobacteria, and Actinobacteria. The 
OTUs that are altered in specific body sites are visualized in Figure 11. 
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Figure 11: The OTUs significantly altered (p<0.01) in psoriasis lesions compared to healthy controls 
in the human skin microbiome. The nodes are labeled with Green Genes OTU numbers, the phyla, 
and the most specific level of categorization that is available with the OTUs such as species (s), genus 
(g), and family (f). The abundance perturbations are noted with an up arrow for higher abundance in 
psoriasis and a down arrow for lower abundance OTUs. The colors represent the body site where the 
OTU is significant (red: elbow, blue: knee). 
 
Metagenome Predictions 
OTU level abundance data alone does not indicate functional alterations that are present in the 
microbiome. Ideally, whole genome shotgun metagenomics of the microbiome need to be 
carried out in order to map the composition of the genes. However, such data is not yet 
available due to technical limitations of sequencing technologies and DNA extraction methods 
[102]. Nonetheless, the genomes that have already been decoded can provide an estimation of 
the gene content of the microbiome [107]. This idea has been implemented in the PICRUST 
software package and utilized in this study. 
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The assigned OTUs have been processed with the PICRUST metagenome prediction package. 
The availability of nearby genome representatives for each microbiome samples were quantified 
with the Nearest Sequenced Taxon Index (NSTI), which is based on the phylogenetic distance of 
each organism in the OTU table to its nearest relative sequenced reference genome [107]. The 
NSTI values quantify the error that is introduced with the prediction algorithm. The average NSTI 
values for each category is shown in Table 5. All NSTI values were within acceptable ranges for 
accurate predictions (NSTI<0.17) according to PICRUST publication [107].  
 
Body Site NSTI values (average ± standard deviation) 
Control Uninvolved Psoriasis Active Psoriasis 
Elbow 0.082±0.052 0.065±0.026 0.078±0.052 
Knee 0.078±0.034 0.092±0.033 0.072±0.023 
Back NA 0.048±0.037 0.040±0.020 
Leg NA 0.068±0.024 0.050±0.021 
Forearm NA 0.045±0.015 0.055±0.019 
Forehead 0.088±0.044 0.151±0.070 NA 
 
Table 5 Average Nearest Sequenced Taxon Index (NSTI) for the microbiome datasets based on 
the phylogenetic distance for each organism in the OTU table to its nearest relative sequenced 
reference genome. All values were within an acceptable range for accurate prediction. 
 
Even though the OTU abundance profiles varied with body site, the gene content of the 
microbiome as a whole demonstrated consistent alterations across the sampled sites. These 
genes were identified by calculating the rank product of the abundance fold changes. The top 25 
orthologs with high abundance and top 25 orthologs with low abundance obtained are 
illustrated in Figure 12. The genes that were commonly altered between the body sites include 
pathogenic genes that were higher in abundance such as yeeJ (adhesion / invasion), yscF, sctF, 
yscW, sctW (type III secretion proteins), pagC (putative virulence related protein), pla, ompT 
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(plasminogen related genes), gspS (type II secretion proteins), and acfC (accessory colonization 
factor). On the other hand, iga (Type V secretion system) and rtxB (Type I secretion system) 
were in lower abundance in psoriasis microbiome.  
The rest of the genes were involved in various metabolic processes. For example, the high 
abundance orthologs RRM1 (ribonucleoside-diphosphate reductase subunit 1) and yjjG (5’-
nucleotidase) and lower abundance orthologs NUDT2 (bis(5’ nuxleosidyl)-tetraphosphatase) are 
part of the pyrimidine and purine metabolism pathways. ACLY is involved in citrare cycle. 
Orthologs that belong to the fructooligosaccharide transport system (msmE, msmF, msmG) 
were in lower abundance. 
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Figure 12 the orthologous genes that are consistently altered in the microbiome comparisons. 
The values represent the log2 transformed fold changes of the metagenome predicted through 
PICRUST software package. The high abundance genes are indicated with shades of red and the 
low abundance genes are indicated with shades of blue. 
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Significantly Altered Pathways in Psoriasis Microbiome 
The pathways with top altered abundance in psoriasis microbiome were identified using the 
Mann-Whitney U test [108]. Statistical significance of vibrio cholera infection, amoebiasis and 
beta-lactam resistance pathways suggest an increase in disease causing orthologs in the 
psoriasis microbiome. (Table 6). Other pathways with increased gene abundance were xylene 
degradation and sporulation. 
Body Site Comparison KEGG Pathway P value Fold Change 
Elbow U/C Vibrio cholera infection 0.0047 1.10 
Knee U/C Xylene degradation 0.0087 1.30 
Forehead U/C Sporulation 0.0064 1.63 
Forehead U/C Amoebiasis 0.0086 2.32 
Forehead U/C Beta-Lactam resistance 0.0094 1.83 
 
Table 6 KEGG pathways that have significantly different (p < 0.01) abundance levels in 
psoriasis microbiome compared to controls calculated with PICRUST [107]. The significance 
was only observed in the microbiome comparisons between uninvolved skin (U) and healthy 
controls (C). The table shows for each listed KEGG pathway, the p-value calculated using the 
Mann-Whitney U test and the abundance fold changes. 
 
Orthologous Genes that are Commonly Altered between Host and the Microbiome 
The orthologs that were commonly altered both on the host and the microbiome pointed to 
common processes in psoriasis. Orthologous genes with significant abundance changes in 
psoriasis microbiome and the host compared to healthy controls are shown in Table 7. ATOX1 is 
a copper chaperone that also functions as antioxidant. AMD1 is involved in polyamine synthesis, 
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GMPPB catalyzes the conversion of mannose-1-phosphate to GDP-mannose, and AKR1B10 is a 
member of the aldo/keto reductase superfamily.  
Comparison Symbol 
Body 
Site 
FC 
Microbiome 
FC 
Host 
KEGG Pathways 
AC ATOX1 elbow 0.71 1.94 Mineral absorption 
  
AU 
AMD1 knee 0.61 1.89 
Cysteine and methionine 
metabolism, Arginine and proline 
metabolism  
GMPPB knee 0.66 1.67 
Fructose and mannose 
metabolism, Amino sugar and 
nucleotide sugar metabolism, 
Biosynthesis of secondary 
metabolites  
AKR1B10 forearm 0.17 20.82 
Pentose and glucuronate 
interconversions, Fructose and 
mannose metabolism, Galactose 
metabolism, Glycerolipid 
metabolism  
 
Table 7: Significantly over- and under-represented genes in psoriasis in the host and the 
microbiome for the A/C and A/U comparisons (p<0.01 for host and p<0.05 for microbiome). 
No commonalities were observed for the U/C comparison. The table reflects the fold changes of 
the commonly altered genes in the microbiome and the host, and p-values resulting from Mann-
Whitney U test. A: active involved skin, U: active uninvolved skin, C: control skin, FC: fold 
change. 
 
Altered KEGG Pathway Expression for Bacterial Invasion of Epithelial Cells in Relation to Skin 
Disease Host Genes 
Bacterial invasion of epithelial cells KEGG pathway [57] depicts mechanisms that bacteria use to 
hijack the actin structure of the cell. Using the Virulence Factor Database (VfDB) [60], bacterial 
genes with pathogenic potential were identified within the pathway, enabling the annotation of 
crosstalk linkages between the host and the psoriasis microbiome. Figure 13 shows the 
pathway, annotated with color markers for upregulated and downregulated genes. Host genes 
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Cbl, SHC1, and ARP 2/3 were upregulated in psoriasis whereas Dynamin, SHC4, PI3K, and Septin 
were downregulated. The pathogenic orthologs that bind to fibronectin (FnBPA, FnBPB, Pfb, 
Sfb1, invasin) used by Staphylococcus, Streptococcus, and Yersinia species were in high 
abundance in psoriasis microbiome, potentially indicating an increase in virulence factors in the 
psoriasis microbiome. 
 
Figure 13 Bacterial invasion of epithelial cells KEGG pathway annotated with the up and 
downregulated gene signatures for psoriasis. The genes targeted by bacteria (blue) and viruses 
(red) obtained from PHISTO database are indicated with lines under the gene boxes. The 
virulence factors obtained from VfDB database are indicated with red stars. The over and 
underrepresented microbial genes obtained from metagenome analysis of the psoriasis 
microbiome are marked with red arrows. PS: psoriasis, up: upregulated genes, down: 
downregulated genes, target_bac: bacterial target, target_vir: viral target.  
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Discussion 
Psoriasis is an autoimmune disease with suspected microbial involvement. The gene contents of 
skin microbiome were predicted from 16S sequencing data in order to understand the 
functional perturbations in psoriasis flares across different body sites. The altered metagenome 
was compared with the microarray gene signatures obtained in Specific Aim 1 to draw parallels 
between the two sides of the coin. 
The OTUs that were significantly altered were members of the phyla, Proteobacteria, Firmicutes, 
Actinobacteria, and Bacteriodetes. The higher abundances of opportunistic pathogens belonging 
to these phyla in psoriasis microbiome suggest pathogenic contributions to the maintenance of 
the psoriatic lesions. For example, Staphylococcus epidermidis had significantly higher 
abundance in knee psoriasis microbiome compared to healthy controls. Even though it is usually 
labeled as a skin commensal, recent evidence shows that due to intravenous catheter insertions 
S. epidermidis is responsible for 22% of the bloodstream infections of the intensive care unit 
patients and is capable of forming biofilms on medical device surfaces [110]. Streptococcus 
genus, which had high abundance in the knee psoriasis microbiome, is notorious for having 
pathogenic strains. Another opportunistic pathogen with high abundance was Anaerococcus, 
which has been observed in chronic diabetic wounds, suggesting the involvement of bacteria in 
chronic skin conditions [111]. The pathogenic membership of the bacteria can only be 
determined accurately with strain level information which can’t be obtained with 16S data. 
However, the genus level information was suggestive of pathogenic contributions to psoriasis. 
The OTUs that were significantly altered in the psoriasis microbiome such as Kochuria, 
Methylobacterium, and Schlegelella are commonly found in soil [112, 113]. Soil associated 
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bacteria have previously been found on the hand microbiome of Tanzanian women and not on 
women residing in the United States. This implicates the effect of environment in shaping the 
microbial skin communities [114]. The abundance differences of soil associated bacteria on 
psoriasis lesions suggests involvement of environmental factors in psoriasis. 
Pathogenic contributions can also be observed in the commonly altered bacterial orthologs 
across different body sites. While selected members of Type II and Type III Secretion Systems 
were among the higher abundance orthologs, Type I and Type V Secretion System orthologs 
were in lower abundance. Type III secretion system utilizes needle like proteins to secrete 
bacterial proteins to its host. The highly abundant orthologs in psoriasis YscF is a protein that 
influences the host immune response [115] and is recognized by Toll-like receptors [116]. As 
mentioned in the first chapter, Toll-like receptor pathway is upregulated in the host psoriasis 
gene signature. Another high abundance protein YscW is responsible for inducing 
immunodeficiency during infection as shown in mice [117]. It is also required for the biogenesis 
of bacterial protein secretion [118]. Type II secretion system is composed of gated channels in 
the outer membrane and require pilotin proteins to assemble around the channels [119]. A 
pilotin protein GspS was consistently altered in the psoriasis microbiome. The virulence 
membrane protein pagC was also highly abundant in psoriasis microbiome. It is regulated by 
phoP-phoQ and is an essential protein in the pathogenesis process [120]. It is also indirectly 
involved in the serum resistance of bacteria [121]. Finally, the genes related to plasminogen 
were in high abundance such as pla and ompT. During infection, pla cleaves the host protein 
plasminogen activator inhibitor (PAI-1). The gene PAI-1 regulates plasminogen which dissolves 
fibrin in clots and degrades laminin. However coagulation activates immune response and may 
help restrain bacteria. Hence, cleaving PAI-1 helps the bacteria hinder the immune system of the 
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host [122]. The pathogenic genes that were consistently in high abundance in the psoriasis 
microbiome suggest mechanisms as to how the immune system may be triggered due to 
dysbiosis of the microbiome. 
On the host side, bacterial invasion of epithelial cells pathway was crowded with significantly 
altered psoriasis genes, consistent with the microbiome signatures observed. For example, the 
ARP2/3 complex was elevated in psoriasis. The complex, involved in actin polymerization, has 
been associated with cell crawling motility with the help of N-WASP and WAVE [123], especially 
for migration of immune cells [124]. ARP2/3 is also significant in organizing tight junctions and 
maintaining epidermal integrity [125]. ARP2/3 upregulation potentially points to hijacking the 
host mechanism of bacterial protein transport using actin structures [126, 127]. The high 
abundance of microbiome genes in this pathway also suggest microbiome involvement. A 
pathogenic component to psoriasis is also suggested by the shared immune response with 
Staphylococcus [128, 129] and Streptococcus [130] skin invasions. Together, these results point 
to a pivotal role the microbial agents play in the initiation and maintenance of psoriatic 
phenotypes.  
The genes that are commonly altered between the host and the microbiome involved metabolic 
genes. GMPPB and AKR1B10 are both involved in the fructose and mannose metabolism 
pathway. They were upregulated in the host and were in low abundance in psoriasis 
microbiome. This finding suggests metabolic competition of the host and the microbiome on the 
skin. Another metabolic gene commonly altered was AMD1, which is an intermediary enzyme to 
produce spermidine. This polyamine spermidine, responsible for keratinocyte proliferation, was 
shown to be significantly higher in psoriasis patients [131]. The analysis also showed that 
microbiome mirrors and complements the oxidative stress of the host. The gene ATOX1 plays a 
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role in copper homeostasis. The alteration of the gene’s expression can be resulting in elevated 
copper levels in the serum of psoriasis patients [132]. 
The OTU and metagenome alterations in the psoriasis microbiome allude to a higher abundance 
of virulence factors, which can be responsible for triggering or the maintaining the immune 
response observed in psoriasis flares. The metabolic contributions of the microbiome and the 
crosstalk should be further evaluated with metabolic analyses. 
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Specific Aim III: Positive Selection Signals in Psoriasis 
The goal of this chapter is to map the selection patterns on the HLA region for populations with 
different ethnic backgrounds. Due to the geographic differences, populations are subject to 
different evolutionary pressures. The HLA region is highly involved with immune response and is 
linked to psoriasis phenotype. I hypothesize that there are population subtype specific regions 
that are under positive selection. Those regions can be the key to explaining the susceptibility 
differences that are observed in psoriasis prevalence. 
 
Introduction 
Susceptibility to disease is dependent on population history in many cases. GWA studies provide 
insight into genetic loci responsible for disease pathogenesis. National databases curate GWAS 
results in order to provide a global view of disease associated polymorphisms [133, 134]. Human 
Leukocyte Antigen (HLA) region, a 4 Mb long region located on the chromosomal position 6p21, 
is crowded with immune genes [135] and multiple polymorphisms [136], which creates and 
extensive repertoire for pathogen identification during immune defense. The region is 
associated with a multitude of conditions through GWA studies. These associations mainly 
consist of autoimmune disorders such as psoriasis [137], rheumatoid arthritis [138] and 
ulcerative colitis [139] as well as infectious diseases such as Hepatitis B [140]and HIV [141, 142]. 
However, GWA studies are typically limited to a small number of patient ethnic population as 
representative subjects, which do not capture susceptibility differences between ethnic 
populations. In this study we investigated the interplay between the SNPs, diseases and 
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population subtypes within the HLA region using open access genomics datasets and 
computational tools. 
Psoriasis has a strong genetic component. Twin studies show that genetic factors explain 68% of 
the variation in psoriasis susceptibility and concordance is higher in monozygotic twins than 
dizygotic twins [143]. Online Mendelian Inheritance in Man (OMIM) [144] has curated 15 
regions associated with psoriasis including the HLA region. Within the different HLA haplotypes, 
HLA-Cw6 and HLA-Bw7 have specifically been associated with psoriasis susceptibility [145]. 
Prevalence differences in psoriasis can be observed in people with different ethnic and genetic 
background. A study done on the United States psoriasis patient population shows that 
Caucasians have the highest prevalence of 3.6%, followed by African Americans with 1.9% and 
Hispanics with 1.4% prevalence [146]. The susceptibility differences are also reflected in global 
studies with lowest incidence in Taiwan (0%) and highest in Denmark (8.5%) [4]. These observed 
susceptibility differences between ethnic populations lead to questions about the selection 
pressures behind the genetic component of diseases. This can be achieved by understanding the 
population history of the highly disease associated HLA region in different ethnic populations.  
Identifying disease causing SNPs in the HLA region in GWAS studies can be misleading due to 
high linkage disequilibrium (LD) in the region [147, 148]. Recombination hotspots have been 
established using linkage disequilibrium based tests in North European [149-151], East Asian 
[152] and African [153] populations. An integrative study has shown that recombination 
hotspots vary for different populations, which explains the high diversity of haplotypes [148] as 
well as the susceptibility differences between populations. This is a comparative study that 
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follows up on those findings and focuses on identifying positive selection in the HLA region by 
making use of the haplotype backgrounds of SNPs typed in different ethnic populations. 
Recent advances have enabled whole genome sequencing, and SNP detection to be cheaper and 
faster, which led to large scale projects to catalog common human genetic variants. The 
HapMap Project provides genotype information on 11 ethnic populations with African, 
European and Asian ancestry [21, 154]. The main objective of the project was to identify the 
haplotypes in different ethnic populations to aid in more accurate association results in GWA 
studies. The diversity of population backgrounds in HapMap make it ideal to study susceptibility 
differences based on haplotype based statistical tests. 
It has been observed by Sabeti et al. that under neutral evolution, low frequency alleles are on 
longer haplotypes and high frequency alleles are on short haplotypes since haplotypes are 
broken down by recombination over time as the allele frequencies rise. The long range 
haplotype test is a method which identifies alleles that have risen to moderate frequency and 
are on unusual length haplotype blocks [155]. Voight et al. has standardized the detection of 
positive selection by comparing the heterozygosity of a SNP to the other SNPs in the genome 
that fall within the same frequency bin [156]. Tang et al. has utilized these ideas to detect 
positions on the genome that have different selection histories in pairwise population 
comparisons [157]. In this study, these tests have been utilized to identify alleles of interest in 
the HLA region. 
In this study, SNPs undergoing recent positive selection in a population and SNPs that have 
different recombination backgrounds in pairwise population comparisons were identified. In 
order to explore this, polymorphisms typed in Phase III HapMap populations [21, 154] were 
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analyzed. Pairwise population comparisons were conducted to find SNPs that were statistically 
significant between populations in order to illuminate prevalence differences. The resulting 
regions of interest were annotated with disease associations through literature searches. The 
results are novel as it produces new insights into the effect of positive selection on disease 
susceptibility in different populations as well as annotation of the HLA region with different 
evolutionary histories through pairwise population comparisons. 
 
Methods 
Identifying Gene Lists 
Genes in the HLA region and their sub-region annotations of class I, class II, extended class II and 
class III were obtained from Shiina et al. [158]. The genomic coordinates of these sub-regions 
obtained from the hg19 build of the human genome [159] can be seen in Table 8. The 
Bioconductor GOstats package [55] was used for statistical enrichment of Gene Ontology 
Biological Process (GO-BP), Gene Ontology Molecular Function (GO-MF) [56] and the Kyoto 
Encyclopedia of Genes and Genomes (KEGG) pathways [57] for the genes in the whole HLA 
region and genes in each sub-region. 
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HLA class Genic Region (hg19) 
on Chr 6 
# of SNPs in Phased 
Data 
# of SNPs with Ancestral 
Allele Information 
Class I 29680000-31480000 2723 1611 
Class III 31480000-32400000 1216 1161 
Class II 32400000-33100000 1141 766 
Class II extended 33100000-33378000 204 201 
Total 29680000-33378000 5284 3739 
 
Table 8: The HLA region coordinates on chromosome 6 partitioned according to their 
functional class annotations as described in Shiina et al. The coordinates are based on the hg19 
build of the genome. The number of SNPs included in the phased genotypes of the HapMap 
populations as well as the number of phased SNPs that have ancestral annotations according to 
the EPO pipeline. 
 
Obtaining Population Level Data 
The phased genotypes and frequency data were downloaded for each ethnic population typed 
in Phase III of the HapMap [21, 154] project. The HapMap database includes populations with 
East Asian ancestry (Japanese in Tokyo-JPT (91 samples), Han Chinese in Beijing-CHB (90 
samples), Chinese in Denver-CHD (100 samples)), European ancestry (Europeans of Northern 
and Western Ancestry-CEU (180 samples) and Toscana- TSI(100 samples)), African ancestry 
(Yorubans-YRI (180 samples), Masaai-MKK (180 samples), Luhya-LWK (100 samples), and African 
Americans-ASW(90 samples)) and other ethnic groups (Gujaratis in Houston-GIH (100 samples), 
and Mexicans in Los Angeles-MEX(90 samples)), making it ideal for identifying susceptibility 
SNPs. The SNP positions were lifted over from hg18 to hg19 build using UCSC tools [160]. The 
hg19 build of the human ancestral genome was acquired from the 6-way primate genome 
alignment using the Enredo-Pecan-Ortheus (EPO) pipeline [22, 161, 162]. 
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Population Differences 
The SNPs that are common between all populations were extracted from the frequency data. 
For each pair of populations, pairwise allele frequency distribution for each subclass as well as 
for the whole HLA region were calculated with Kolmogorov-Smirnov (KS) test [163]. The p values 
were corrected for false discovery rate (FDR) using Benjamini-Hocheberg correction [58]. The 
same test was carried out for 20 concatenated autosomal loci that are under neutral selection 
as described by Wall et al. [164] in order to observe neutral estimate of allelic variation and to 
establish that the frequency differences seen at the HLA regions are not a result of demographic 
forces but signify selection. 
For a population, the Integrated Extended Haplotype Homozygosity (IHH) [155] and the 
Integrated Site-specific EHH (iES) [157] of the ancestral and derived alleles were calculated for 
each typed SNP in order to find the transmission of extended haplotypes without 
recombination. The IHH of a SNP was standardized with respect to the results from the whole 
genome that fall within the same 0.025 frequency bin using the Standardized IHH (iHS) test 
[156]. SNPs with a minor allele frequency of 0.05 were discarded from the analysis since the iHS 
method is not applicable for alleles that are fixed or almost fixed in a population. Finally 
standardized ratio of iES from pairwise populations (Rsb) were calculated for each SNP [157]. 
The resulting p values of the iHS and Rsb tests were adjusted for multiple testing using 
Benjamini-Hochberg FDR correction [58]. The HLA region of interest was then extracted from 
the whole genome analyses. 
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Polymorphism Annotations 
The SNPs were annotated according to their location as intergenic, intron, coding, UTR and 
promoter [165]. The intergenic SNPs were annotated with genes present within a 20 Kb 
upstream and downstream window. The SNPs that are under positive selection and the genes 
they are on are also cross-referenced with diseases they are associated with through MalaCards 
[166] and National Human Genome Research Institute GWAS Catalog [133]. 
 
Results 
This study presents a systematic approach to detect positive selection in the extended HLA 
region in order to explain demographic susceptibility differences of HLA linked conditions. The 
SNPs that are associated with a condition can be hitchhiking on the haplotype blocks that are 
under selection. By detecting the driving SNPs on the haplotype blocks, more information on the 
hitchhiking SNPs can be obtained. 
The analysis utilizes genotypes of 11 HapMap populations [21, 154] consisting of 2022 
haplotypes with 12622 typed SNPs in the HLA region. Among these typed SNPs, 5284 of them 
have phased data and 3739 have ancestral alleles deduced from the EPO pipeline [22, 161, 162]. 
The definitions of the sub-classes of the HLA region as well as the breakdown of the number of 
SNPs typed in each sub-region can be seen in Table 8. The phased data of the SNPs are then 
used to find positive selection in each HapMap population, as well as to find SNPs that have 
significantly different population histories. The resulting SNPs of interest are then annotated 
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with diseases they are associated with through GWA studies. The overall workflow is 
summarized in Figure 14. 
 
 
Figure 14 Flowchart of the analysis shows the steps taken to obtain the SNPs that are under 
positive selection in the HLA region for each population as well as identifying the SNPs that have 
significantly different population histories.  
 
Functional Annotation of the HLA Region 
The HLA is a dense genic region with exclusive immune function. This is represented by the 
functional annotations of genes in this region through Gene Ontology [56] and KEGG pathways 
[57]. The KEGG annotations are represented in the Table 9. KEGG pathways that are enriched 
with genes in the HLA region are involved in autoimmune conditions such as type-I diabetes, 
asthma and rheumatoid arthritis as well as infections such as Leshmanaiasis, Staphylococcus 
aureus and Toxoplasmosis. The biological processes they are involved in include interferon-
gamma-mediated signaling pathway, antigen processing and presentation and positive 
regulation of immune response. Top molecular function terms that are enriched with HLA genes 
include peptide antigen binding, MHC class II receptor activity and amide binding. The 
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annotations are primarily for the Class I and Class II, while Class III and extended Class II region 
do not have any significant terms associated with them. 
 
Pathways Class I Class II all HLA 
Antigen processing and presentation 0.08 0.18 0.33 
Allograft rejection 0.16 0.32 0.51 
Autoimmune thyroid disease 0.12 0.23 0.35 
Cell adhesion molecules (CAMs) 0.05 0.09 0.14 
Graft-versus-host disease 0.15 0.29 0.46 
Phagosome 0.05 0.09 0.14 
Type I diabetes mellitus 0.14 0.28 0.47 
Viral myocarditis 0.09 0.17 0.26 
Asthma  0.40 0.43 
Endocytosis 0.03  0.04 
Intestinal immune network for IgA production  0.25 0.25 
Leishmaniasis  0.17 0.18 
Natural killer cell mediated cytotoxicity 0.04  0.06 
Rheumatoid arthritis  0.13 0.16 
Staphylococcus aureus infection  0.22 0.27 
Systemic lupus erythematosus  0.09 0.11 
Toxoplasmosis  0.09 0.12 
ABC transporters  0.05  
Hematopoietic cell lineage  0.03  
Primary immunodeficiency  0.06  
Proteasome  0.05  
Spliceosome    
 
Table 9: Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways that are enriched with 
all HLA genes and sub-classes of genes. The terms are significant (Benjamini < 0.01) in at least 1 
gene list. The terms are listed as most commonly enriched to region specific terms. The values 
represent the ratio of genes in the term that overlap with the gene list. The cells that are left 
blank signifies that the corresponding term is not enriched for that gene list. There were no 
terms enriched for extended class II region, hence its corresponding column is not shown. 
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Allele Frequency Distributions of HLA sub-Region 
The allele frequency distributions of the HLA region were compared between populations with 
Kolmogorov-Smirnov (KS) test in order to find the populations that have distinguishing patterns 
of allele histories. The –log10 of the Benjamini corrected p values of pairwise tests are 
represented as heatmaps in Figure 15. The results for the whole HLA region show significantly 
different allele frequency distributions for CEU, TSI and JPT populations compared to all other 
ethnic populations. When the HLS region is broken down into sub-regions, it is seen that each 
sub-region has a different population history, Class I region being the greatest contributor to 
frequency distribution diversity between populations. European ancestry (CEU and TSI) 
difference is apparent in Class I region whereas East Asian (JPT+CHB+CHD) and CEU difference 
dominates in the Class II region. In the extended Class II region, regional coherence patterns can 
be observed where the allele frequency distributions are similar within African, East Asian and 
European descent populations. When the test is applied to neutrally evolving autosomal regions 
in the genome [164], there were no significant differences between the populations. This 
signifies that the allele frequency distribution variations are not a result of population 
demography but can explain different selection signals in populations. 
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All HLA Region Class I Class III 
   
Class II Class II-Extended  
   
 
Figure 15: Heatmaps of pairwise SNP allele frequency distribution comparisons using the 
Kolmogorov-Smirnov (KS) test for each cluster. The values represent the -log10 of the Benjamini 
FDR corrected KS-test p values. The comparisons that are not significant (Benjamini >0.05) are in 
black. 
 
Polymorphisms on the HLA that are Under Positive Selection 
To further investigate the selection signals, recent positive selection on the HLA variants that 
have not yet reached fixation have been calculated with the iHS test. The –log10 of the 
corrected p values for different ethnic populations have been overlapped on the scatter plot in 
Figure 15. A complete and more detailed annotations of the significant SNPs, as well as the 
genes they fall within are provided in Appendix C. The tests are also able to detect if the 
selection is on the ancestral or the derived allele. With the exception of five SNPs, selection 
signals are on derived alleles. Similar to the results obtained from the KS heatmaps, there are 
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European ancestry specific selection peaks in Class I region. Coding and intronic SNPs that are on 
PSORS1C1, TCF19, MUC22, TRIM10 and TRIM15 are under positive selection with a Benjamini 
cutoff of 0.01. The polymorphisms with the highest significance value, rs3130557, is driving the 
selection in both CEU and TSI populations. The SNP is located on the intronic region on the 
PSORS1C1 gene. In the Class III region, there is positive selection signals for the East Asian 
populations, especially on the genes NOTCH4, C6orf10 and BTNL2. The driving polymorphism 
across populations are rs3132946, rs3830041, rs8192565 and rs12055568 which are intronic or 
promoter SNPs on the NOTCH4 gene. The East Asian specificity continues on to the Class II genes 
with positive selection on TAP2. There is African ancestry specific positive selection signals on 
Class II genes, specifically HLA-DOA and HLA-DPA, both HLA class II alpha chain paralogues 
expressed in antigen presenting cells. The driving SNPs in this region are rs3129304, rs3129303 
and rs10947368 which are found on 3’ UTR and coding region of the HLA-DOA gene. The SNPs of 
interest from the iHS test and the genes that they fall under have been annotated through the 
MalaCards database and summarized in Table 10. The associations range from autoimmune 
conditions such as psoriasis, rheumatoid arthritis and celiac disease to infections such as HIV-I.  
The tests were followed up with pairwise population comparisons of haplotype background 
using the Rsb test. The SNPs that are statistically significant between populations from different 
geographical backgrounds are visualized in Figure 17. The results from the iHS test have been 
confirmed with the Rsb test. The SNPs that distinguished between ethnic regions were on 
PSORS1C1, NOTCH4, C6orf10 and HLA-DOA. The SNP rs3130557 on PSORS1C1 gene that is under 
positive selection for the European populations show differences in ASW and TSI populations. 
The SNPs that are on HLA-DOA gene under positive selection for the LWK population also shows 
significant difference with the TSI population. These SNPs can be responsible for the 
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susceptibility differences that is observed between populations for the diseases associated with 
the genes. 
 
 
Figure 16: Superposition of –log10 of the Benjamini corrected iHS p-values of all HapMap 
populations along the HLA region. The horizontal red line represents cutoff for significance 
(Benjamini < 0.01). Class I region shows evidence of positive selection with European (CEU, TSI) 
specificity, non-specific ethnic background positive selection in Class III, African (LWK, YRI) 
specificity in the Class II region and no positive selection in extended Class II region. 
80 
 
 
 
Figure 17: The SNPs with significantly different evolutionary backgrounds between at least 
two populations belonging to different geographical regions (Benjamini < 0.01). The 
standardized ratio of integrated site-specific EHH from pairwise populations (Rsb) on the HLA 
region were calculated. Each box represents a gene annotated with the SNPs that have 
significantly different evolutionary backgrounds. The genes are labeled with the HLA sub-regions 
they belong to. 
 
Overall, the study shows that there are discrete patterns of selection for populations that 
belong to different geographical regions. Selections signals are concentrated in the Class I region 
for the European descent populations and Class II for the African descent populations. 
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Gene 
Associated Disease 
autoimmune infection inherited cancer other 
C
la
s
s
 I
 
TRIM31 
 
lymphocytic 
choriomeningitis    
TRIM26 
   
endodermal sinus tumor seizure disorder 
HCG22 
   
follicular lymphoma 
 
CDSN guttate psoriasis 
 
hypotrichosis simplex, 
peeling skin syndrome   
C6orf15 
   
follicular lymphoma 
 
PSORS1C1 
psoriasis, epidermal necrolysis, stevens-johnson 
syndrome, rheumatoid arthritis     
CCHCR1 psoriasis 
    
TCF19 
  
tetraploidy 
  
PSORS1C3 psoriasis 
    
POU5F1 
   
Pineoblastoma, 
germinoma, teratoma 
seborrheic keratosis 
C
la
s
s
 I
II
 
DDX39B rheumatoid arthritis 
    
LST1 
    
hyperbilirubinemia 
PRRC2A rheumatoid arthritis, diabetes mellitus 
   
coronary artery aneurysm 
APOM type 2 diabetes mellitus 
   
limb ischemia 
CSNK2B egg allergy 
    
NOTCH4 
   
salivary gland tumor 
schizophrenia, 
pseudobulbar palsy 
BTNL2 sarcoidosis, wegener's granulomatosis 
    
C
la
s
s
 I
I 
TAP2 
wegener-like granulomatosis, ankylosing spondylitis, 
cardiac sarcoidosis, celiac 
echinococcosis 
type I bare lymphocyte 
syndrome 
melanoma 
 
HLA-DOA 
 
HIV-I 
   
HLA-DPA1 
chronic berylliosis, wegener's granulomatosis, myelitis, 
neonatal lupus erythematosus, rheumatoid arthritis 
rubella 
  
pulmonary hypertension 
HLA-DPB1 
  
dysplasia 
  
Table 10: Diseases that are associated with the genes under positive selection (iHS Benjamini < 0.01) in at least one HapMap population. The 
diseases associated with the gene under positive selection are separated as autoimmune, infection, inherited, cancer and other. Genes are 
sorted according to their genomic positions. The associated diseases are obtained through the MalaCards database.  
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Discussion 
Psoriasis is a skin condition with a strong genetic component. HLA region has shown associations 
with the condition through GWAS studies. In this chapter, the SNPs that are undergoing positive 
selection in the HLA region have been identified through haplotype based statistical methods. 
The overall results showed partitioning of the positive selection signals according to ethnic 
background of populations. Positive selection on the Class I region was observed exclusively in 
populations with European background. Genes that are on the MHC Class I region are mainly to 
differentiate self from non-self. Hence they are highly associated with autoimmune conditions. 
Positive selection on the Class II region could be observed in populations with African ancestry. 
Genes on this region are necessary for establishing an immune response. The positive selection 
patterns are consistent with the infection based evolutionary pressures that are present in the 
African ancestry populations [167]. 
The SNPs that are on the intronic region of PSORS1C1 are undergoing positive selection in the 
European ancestry populations. The gene has been associated with psoriasis [168] and its 
comorbidity rheumatoid arthritis [169]. These results are consistent with the observation that 
psoriasis has a higher prevalence in the Caucasian ethnic population than African ancestry 
populations [4]. The driving SNP with the highest p value for positive selection signal is also on 
the PSORS1C1 gene. The SNP rs3130557 is associated with multiple autoimmune conditions 
such as ulcerative colitis [170], Crohn’s [171] and coeliac diseases [134] as well as association 
with glycemic traits [172]. It also shows significant difference between the TSI and ASW 
populations according to the cross population test performed. The positive selection in the 
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region may be the driving force behind the high psoriasis rates in the Caucasian population 
through genetic hitchhiking. 
The gene undergoing positive selection in the East Asian ancestry populations is NOTCH4. It is a 
gene that is responsible for cell fate regulation. NOTCH4 has been associated with schizophrenia 
in the Chinese Zhuang and Chinese Han population for the SNP rs3131296 [173]. Even though 
that SNP is not significant in our analysis, it is within 20kb of the positively selected region. This 
may again indicate that the SNP that is associated with a condition may be a result of positive 
selection in the neighboring regions for a population. 
Genes that are under positive selection in the African population comprise of HLA-DOA. It is a 
gene that is expressed in B cells. Even though the nucleotide sequences are well conserved 
among these species in order to conserve function [174], positive selection has been observed 
in the African ancestry population. It has also been associated with HIV [166] which poses as a 
recent environmental pressure in the geographical region. 
A limitation of this method is the dependence of the calculations on the ancestral genome build. 
The ancestral genome obtained from the EPO pipeline is not mapped for genes such as HLA-C 
and HLA-B genes potentially due to the high variance in those genes. Therefore the selection 
signatures on the coding regions of those genes could not be obtained. However, positive 
selection detected on the non-coding regions can contribute to the regulation of the genes and 
provide equally valuable information. 
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Overall, the positive selection signatures on the HLA region can help understand the driving 
pressures behind susceptibility to conditions in different ethnic populations, including a complex 
disease with genetic origins such as psoriasis. 
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Conclusions 
Psoriasis is a complex disease with genetic and environmental dimensions. Psoriasis is linked to 
a combination of multiple risk factors such as the genetic susceptibility polymorphisms in the 
HLA region and the suspected microbial involvement. In order to understand the interplay 
between the different factors, an integrated survey of the high throughput datasets need to be 
conducted. This thesis presents the first study to integrate the microarray and microbiome 
results for psoriasis in order to evaluate the cross talk between the host and the microbiome. It 
is also the first study to provide a metagenome analysis of the skin microbiome even if the gene 
content was predicted from 16S abundance data.  
In this thesis, psoriasis transcriptome was studied using open source mRNA microarray datasets 
which provided a large cohort of samples to analyze psoriasis in the context of other 
inflammatory skin conditions, skin cancer, and wound healing. Psoriasis transcriptome was 
highly consistent across different studies which suggests that the manifestation of the disease is 
uniform across different patient cohorts and the technologies that have been used were 
reliable. The genes that are consistently altered across different datasets provided a distinctive 
signature for psoriasis from other inflammatory skin conditions. On the other hand, 
transcriptome similarities could be observed between psoriasis and wound healing. This was 
consistent with clinical observations that psoriasis is a disease of hyper-proliferating 
keratinocytes with an inflammatory component. The pathways that were enriched with 
significantly altered psoriasis genes showed inflammatory signatures. The genes that are 
exclusive to either psoriasis or wound healing such as IL-19, CXCL9, and CXCL11 can be explored 
as drug targets. This would reduce the side effects and balance between the healthy 
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inflammatory responses needed for healing and the inflammatory response that is responsible 
for the autoimmune aspect. Psoriasis gene signature also suggested a pathogenic component to 
the disease. Its gene signature overlapped with pathogenic KEGG pathways such as bacterial 
invasion of epithelial cells. The upregulation of immune response and antimicrobial genes as 
well as their overlap with pathogenic pathways required a microbiome analysis to illuminate the 
role of crosstalk between the host and the microbiome in the maintenance of psoriatic flares. 
The microbiome of psoriasis has been evaluated through multiple 16S studies to compare the 
psoriasis flares as well as healthy control cohorts. Even though 16S data is very useful in 
understanding the bacterial composition of the skin, 16S alone does not answer questions about 
the functional perturbations. Until the DNA extraction and technologies are developed to 
reliably conduct a metagenomics analysis of the skin microbiome, 16S and previously annotated 
bacterial genomes can be used to predict the genomic content of a microbial community. This 
thesis provides a novel approach to understand the functional perturbations caused by the 
microbiome in psoriasis flares. The results from the analysis of open source 16S psoriasis 
datasets show overabundance of opportunistic bacteria such as the OTUs belonging to the 
genera Corynebacterium and Staphylococcus in the psoriasis microbiome. The functional 
perturbations that are common across different body sites show an overabundance of virulence 
factors in the psoriasis microbiome such as yeeJ (adhesion / invasion), yscF, sctF, yscW, sctW 
(type III secretion proteins), pagC (putative virulence related protein), pla, ompT (plasminogen 
related genes), gspS (type II secretion proteins), and acfC. The overabundance of the virulence 
factors and their intersection with the bacterial invasion of epithelial cells pathway suggests 
virulence factors affecting the pathogenesis or maintenance of the psoriasis flares. 
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Aside from the environmental factors affecting psoriasis, genetic factors also play great part in 
the susceptibility to psoriasis. Extended HLA is a 4 Mb long region located on the chromosomal 
position 6p21. It is a gene dense region with critical immune functions for initiating the adaptive 
immune response and distinguishing self from non-self. Single nucleotide polymorphisms (SNPs) 
and genes in this region have been associated in literature with many conditions, including 
psoriasis. In order to identify susceptibility SNPs in the HLA region, the SNPs typed in the 
HapMap data (11 ethnic populations) within the HLA region have been analyzed using extended 
haplotype homozygosity based tests to identify positive selection on polymorphisms that have 
not yet reached fixation. Results show regional specificity of positive selection signals on the 
sub-classes of HLA. The positive selection signals in Class I sub-region show European ancestry 
specificity with intronic SNPs on genes PSORS1C1, TCF19, MUC22, TRIM10 and TRIM15. In the 
Class III region, there is positive selection signals for the East Asian populations, especially on 
the genes NOTCH4, C6orf10 and BTNL2. Finally, there is African ancestry specific positive 
selection signals on Class II genes, specifically HLA-DOA and HLA-DPA; both HLA class II alpha 
chain paralogues expressed in antigen presenting cells. The cross population tests show there 
are more haplotype differences within the same geographical populations than between. Similar 
to single population tests, cross population test results show that the significant SNPs are 
concentrated in the Class II region for African ancestry populations, whereas for European 
ancestry populations, they are concentrated in the Class I region. 
Three techniques were developed and applied in this thesis to explore a complex skin condition. 
The methods used in the microarray analysis of psoriasis revealed that psoriasis had consistent 
gene signatures that showed upregulation of immune function, keratinization, and antimicrobial 
activity. The microbiome analysis showed that there were composition differences in psoriasis 
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patients compared to healthy cohorts. The analysis also demonstrated that the functional 
perturbations presented an overabundance of virulence factors. Scanning the HLA region for 
positive selection across populations with different ethnic backgrounds indicated that there are 
region specific signals for each class of HLA genes. Together, these approaches comprise a 
systems biology approach to tackle complex diseases. The methods that are explored in this 
thesis can be applied to other conditions to better understand their mechanisms, explore the 
environmental effects, and identify new drug targets. 
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Future Work 
This research describes a pipeline to evaluate the gene expression and microbiome 
perturbations linked to psoriasis as well as the genetic implications of a complex disease. The 
explained pipeline can be extended to evaluate other autoimmune disease and complex 
conditions as more open source data accumulates.  
The biomarkers for psoriasis expression in the host that have been identified through 
computational analysis need to be validated for accuracy and efficacy in patient population. The 
microbiome genes identified through metagenome prediction in the second chapter also need 
to be validated through deep sequencing, preferably for the same patient population. These 
require a large patient cohort, IRB approval and assay development, which is beyond the scope 
of the project.  
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Appendices 
Appendix A 
Psoriasis upregulated genes (Benjamini < 0.01 and fold change > 1.5) overlapped with 
Rheumatoid Arthritis KEGG pathway. Genes belonging to IL-17 immune response are commonly 
altered between psoriasis and rheumatoid arthritis. AC_down: psoriasis A/C consensus 
downregulated gene signature, AC_up: psoriasis A/C consensus upregulated gene signature, 
AU_down: psoriasis A/U downregulated consensus gene signature, AU_up: psoriasis A/U 
upregulated consensus gene signature. 
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Appendix B 
Psoriasis upregulated genes (Benjamini < 0.01 and fold change > 1.5) overlapped with Dilated 
Cardiomyopathy KEGG pathway. The pathway is crowded with downregulated genes in psoriasis 
transcriptome. AC_down: psoriasis A/C consensus downregulated gene signature, AC_up: 
psoriasis A/C consensus upregulated gene signature, AU_down: psoriasis A/U downregulated 
consensus gene signature, AU_up: psoriasis A/U upregulated consensus gene signature. 
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Appendix C 
The average frequencies of the HLA alleles that are under positive selection (iHS Benjamini < 0.01) in at least one population. The SNPs under 
positive selection are in bold. The SNPs are labeled according to the sub-regions they are located on (Class I, Class III, Class II). The allele column 
represents if the selection is on the ancestral allele (A) or derived allele (D). The SNPs are sorted according to their genomic positions. They are 
also annotated with the gene they are located on (intron, coding, UTR, promoter) or around (intergenic within 20K basepairs). The iHS is not 
calculated for frequencies above 0.95 and below 0.05. The SNPs that don't have any frequency data for a population are left blank. 
 
   Average Frequencies of the Alleles under Selection    For intergenic SNPs 
 
SNPs 
All
ele 
mkk lwk yri asw chb jpt chd ceu tsi gih mex position location 
Gene 
Symbol 
Preceding 
Gene 
Following 
Gene 
C
la
s
s
 I
 
rs9261434 D 0.042 0.023 0.044 0.026 0.004 0.033 0.009 0.106 0.123 0.079 0.052 30087776 intergenic 
 
TRIM40 TRIM31 
rs3094134 D   0.005 0 0.009 0 0.015 0.009 0.093 0.108 0.03 0.043 30122154 coding TRIM10 
  
rs1573296 D 0.042 0.005 0 
 
0 0 
 
0.111 0.049 
 
0.026 30127805 intron TRIM10 
  
rs2523729 D 0.022 0.064 0.058 0.035 0 0 
 
0.111 0.049 
 
0.017 30137387 intron TRIM15 
  
rs9261538 D   0.005 
 
0.009 
 
0.015 0.009 0.088 0.103 0.035 0.043 30143491 intergenic 
 
TRIM26 
TRIM10, 
TRIM15 
rs3129988 D   
 
0 0.009 0 0 
 
0.084 0.059 0.005 0.026 30769478 
    
rs1264361 D 0.01 0.023 0.02 0.053 
 
0.007 0.005 0.128 0.049 0.015 0.043 30777498 
    
rs886424 D 0.01 0.023 0.021 0.053 0 0.007 0.005 0.128 0.05 0.015 0.043 30782002 
    
rs1264353 D   
 
0.024 
 
0 0 
 
0.172 
  
  30787762 
    
rs1264350 D 0.013 0.027 0.02 0.061 0.004 0.044 0.037 0.125 0.083 0.005 0.043 30796545 
    
rs1634721 D 0.006 0.018 0.003 
 
0 0 
 
0.116 0.044 
 
0.026 30977680 intron MUC22 
  
rs9357105 D   
 
0.014 
 
0.066 0.117 0.101 0 0.005 0.005 0.009 31003923 intergenic 
 
HCG22 MUC22 
rs3130544 D   0.018 0.003 
 
0 0 
 
0.115 0.054 
 
0.026 31058340 
    
102 
 
rs2256962 D   
  
0.018 
   
0.102 0.054 0.005 0.035 31065620 intergenic 
 
CDSN, 
PSORS1C1, 
C6orf15 
 
rs2233956 D 0.029 0.023 0.01 0.053 0.009 0.026 0.028 0.204 0.137 0.208 0.086 31081205 promoter 
PSORS1C
1   
rs4410768 D 0.026 0.041 0.003 0.018 0.106 0.022 0.014 0.009 0.005 0.094 0.009 31089708 intron 
PSORS1C
1   
rs3130557 D   0.032 0.024 0.035 0 0 
 
0.115 0.069 
 
0.026 31094703 intron 
PSORS1C
1   
rs28732100 D 0.022 
  
0.018 0.009 0.029 0.028 0.084 0.049 0.198 0.017 31104593 intron 
PSORS1C
1   
rs2233952 D   
 
0 0.035 0.031 0.069 0.046 0.133 0.098 0.059 0.086 31105891 intron 
PSORS1C
1   
rs1265097 D 0.101 
 
0.222 0.102 0.022 0.102 0.043 0.099 0.167 0.126 0.245 31106459 coding 
PSORS1C
1   
rs1265083 D 0.022 0.009 0.054 
 
0 0 
 
0.004 0.015 
 
0.069 31111347 intron CCHCR1 
  
rs130072 D 0.019 0.05 0.082 0.026 0.022 0.077 0.041 0.071 0.137 0.1 0.147 31112484 coding CCHCR1 
  
rs7750641 D 0.013 0.023 0.003 
 
0.004 0.004 0.005 0.112 0.059 0.005 0.034 31129310 coding TCF19 
  
rs2073724 D 0.019 0.05 0.092 0.035 0.022 0.077 0.041 0.071 0.137 0.099 0.147 31129707 coding TCF19 
  
rs17190776 D 0.019 0.05 0.092 0.035 0.022 0.077 0.041 0.071 0.137 0.099 0.147 31130865 threeUTR TCF19 
  
rs3130933 D 0.048 
 
0 0.026 0.062 0.029 0.009 0.159 0.093 0.03 0.043 31132085 intergenic NA 
PSORS1C3, 
POU5F1 
CCHCR1, 
TCF19 
C
la
s
s
 I
II
 
rs9267487 D 0.157 0.068 0.017 0.061 0.018 0.033 0.018 0.066 0.064 0.163 0.121 31511350 promoter DDX39B 
  
rs28732144 D 0.105 0.055 0.003 0.018 
 
0.018 0.014 0.058 0.029 0.158 0.034 31556205 intron LST1 
  
rs17207190 D 0.099 0.055 0.003 0.018 
 
0.018 0.009 0.053 0.029 0.15 0.034 31569520 intergenic 
 
AIF1, 
PRRC2A 
NCR3, 
LTB, LST1 
rs35502919 D   
  
0.018 
   
0.058 0.01 
 
  31604355 coding PRRC2A 
  
rs3117582 D 0.048 0.014 0.041 0.026 0 0 
 
0.08 0.064 
 
0.026 31620520 intron APOM 
  
rs3132449 D 0.049 0.023 0.044 0.026 
   
0.08 0.064 
 
0.035 31626013 intergenic 
 
CSNK2B, 
C6orf47, 
LY6G5B, 
GPANK1, 
LY6G5C 
APOM, 
BAG6 
rs9267531 D 0.045 0.023 0.048 0.026 0 0 
 
0.08 0.064 
 
0.034 31636742 threeUTR CSNK2B 
  
rs2854050 D 0.042 0.037 0.027 0.035 0.221 0.199 0.174 0.062 0.034 0.069 0.123 32185605 intron NOTCH4 
  
rs2071282 D   0.005 0.003 
 
0.102 0.062 0.032 0.004 
 
0.01 0.018 32188943 coding NOTCH4 
  
rs3132946 D   
 
0.007 0.018 0 0.018 0.009 0.168 0.074 0.03 0.052 32190028 intron NOTCH4 
  
rs3830041 D 0.256 0.2 0.218 0.123 0.195 0.12 0.092 0.084 0.108 0.183 0.121 32191339 intron NOTCH4 
  
rs8192565 D 0.035 0.005 0.031 0.079 0.133 0.088 0.096 0.075 0.113 0.153 0.052 32191607 intron NOTCH4 
  
rs12055568 D 0.074 0.046 0.007 
 
0.128 0.193 0.197 0.013 0.039 0.005 0.121 32192083 promoter NOTCH4 
  
103 
 
rs549182 D 0.105 0.138 0.106 0.096 0.15 0.106 0.069 0.009 0.044 0.11 0.086 32205045 intergenic 
  
NOTCH4 
rs549270 D 0.125 0.164 0.126 0.158 0.15 0.109 0.087 0.013 0.07 0.149 0.138 32205072 intergenic 
  
NOTCH4 
rs2073047 A   
 
0 
 
0.084 0.15 0.156 0 
  
0.026 32335899 intron C6orf10 
  
rs2076535 D 0.003 0.005 
  
0.181 0.077 0.018 0.004 0.005 0.054 0.017 32339511 fiveUTR C6orf10 
  
rs3763309 D 0.077 0.041 0.071 0.088 0.084 0.102 0.11 0.265 0.162 0.198 0.267 32375973 promoter BTNL2 
  
rs3763310 D   
 
0 
 
0.066 0.047 0.046 0 
  
  32376103 promoter BTNL2 
  
rs3763312 D 0.077 0.036 0.071 0.088 0.085 0.103 0.11 0.265 0.158 0.198 0.267 32376348 promoter BTNL2 
  
C
la
s
s
 I
I 
rs9784876 A 0.154 0.195 0.272 0.246 0.106 0.018 0.009 0.058 0.094 0.104 0.086 32788878 intron TAP2 
  
rs4148876 D 0.064 
 
0 0.018 0.167 0.085 0.042 0.093 0.049 0.035 0.103 32796793 intron TAP2 
  
rs2228391 D 0.006 0.005 
  
0.049 0.089 0.087 
  
0.045   32797773 coding TAP2 
  
rs3128935 D 0.157 0.359 0.293 0.228 0.164 0.172 0.165 0.04 0.054 0.104 0.095 32972404 threeUTR HLA-DOA 
  
rs3129304 D 0.053 0.252 0.219 0.205 0.04 0.084 0.041 0.159 0.114 0.03 0.371 32973743 threeUTR HLA-DOA 
  
rs3129303 D 0.074 0.264 0.221 0.211 0.04 0.088 0.046 0.159 0.114 0.03 0.371 32973878 threeUTR HLA-DOA 
  
rs10947368 D 0.051 0.243 0.221 0.105 0 0 
 
0 
  
  32975341 coding HLA-DOA 
  
rs364950 A 0.087 0.405 0.299 0.193 0 0 
 
0.04 0.044 
 
0.034 32975896 coding HLA-DOA 
  
rs404557 D 0.087 0.405 0.306 0.193 0 0 
 
0.04 0.044 
 
0.034 32976927 intron HLA-DOA 
  
rs3763342 A 0.201 0.366 0.4 0.36 0.354 0.233 0.192 0.133 0.213 0.273 0.172 32978997 promoter HLA-DOA 
  
rs3763341 A 0.125 0.268 0.226 0.184 0.353 0.19 0.154 0.106 0.153 0.267 0.112 32979020 promoter HLA-DOA 
  
rs2116263 D 0.056 0.255 0.243 0.158 0.465 0.471 0.573 0.031 0.02 0.079 0.017 33025493 intergenic 
 
HLA-DPA1, 
HLA-DPB1  
rs4551215 D 0.099 0.257 0.252 0.184 0.465 0.533 0.61 0.04 0.025 0.149 0.026 33025700 intergenic 
 
HLA-DPA1, 
HLA-DPB1  
rs4582419 D 0.055 0.257 0.245 0.184 0.478 0.537 0.602 0.045 0.025 0.149 0.034 33040138 intron HLA-DPA1 
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